Gene Symbol | Gene ID | Gene Info |
---|---|---|
Rfx3
|
ENSMUSG00000040929.10 | regulatory factor X, 3 (influences HLA class II expression) |
Rfx1
|
ENSMUSG00000031706.6 | regulatory factor X, 1 (influences HLA class II expression) |
Rfx4
|
ENSMUSG00000020037.9 | regulatory factor X, 4 (influences HLA class II expression) |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr8_84066182_84066879 | Rfx1 | 304 | 0.625008 | -0.09 | 5.0e-01 | Click! |
chr19_27904687_27904996 | Rfx3 | 3946 | 0.286683 | 0.59 | 2.5e-06 | Click! |
chr19_27904353_27904521 | Rfx3 | 3542 | 0.297613 | 0.58 | 3.8e-06 | Click! |
chr19_28010780_28010937 | Rfx3 | 68 | 0.974083 | 0.55 | 1.3e-05 | Click! |
chr19_27906087_27906262 | Rfx3 | 5279 | 0.265413 | -0.45 | 5.6e-04 | Click! |
chr19_27780178_27780329 | Rfx3 | 56593 | 0.132444 | -0.26 | 5.3e-02 | Click! |
chr10_84755702_84756130 | Rfx4 | 146 | 0.967176 | 0.94 | 1.4e-26 | Click! |
chr10_84755143_84755591 | Rfx4 | 695 | 0.737904 | 0.92 | 1.1e-23 | Click! |
chr10_84759995_84760379 | Rfx4 | 2051 | 0.369321 | 0.91 | 2.4e-22 | Click! |
chr10_84822817_84823117 | Rfx4 | 11779 | 0.202604 | 0.90 | 1.1e-20 | Click! |
chr10_84760401_84760624 | Rfx4 | 1726 | 0.414784 | 0.89 | 2.4e-19 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_18949823_18950240 | 191.24 |
Nova2 |
NOVA alternative splicing regulator 2 |
24143 |
0.07 |
chr18_60925120_60925333 | 185.35 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
392 |
0.8 |
chr1_37220253_37220450 | 179.27 |
Cnga3 |
cyclic nucleotide gated channel alpha 3 |
1146 |
0.49 |
chr15_10011651_10011840 | 176.85 |
Prlr |
prolactin receptor |
165493 |
0.04 |
chr8_86438726_86438901 | 173.89 |
Abcc12 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 12 |
95934 |
0.07 |
chr3_117826862_117827070 | 162.57 |
Snx7 |
sorting nexin 7 |
4308 |
0.26 |
chr18_60925459_60925693 | 158.63 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
42 |
0.97 |
chr10_20944709_20944873 | 157.25 |
Ahi1 |
Abelson helper integration site 1 |
7756 |
0.23 |
chr1_85917187_85917621 | 152.35 |
4933407L21Rik |
RIKEN cDNA 4933407L21 gene |
11079 |
0.12 |
chr16_42718124_42718429 | 151.87 |
Gm49739 |
predicted gene, 49739 |
54350 |
0.16 |
chr12_29871996_29872873 | 145.66 |
Myt1l |
myelin transcription factor 1-like |
20886 |
0.24 |
chr14_52003889_52004971 | 142.08 |
Arhgef40 |
Rho guanine nucleotide exchange factor (GEF) 40 |
58 |
0.93 |
chr9_59589144_59589327 | 134.89 |
Celf6 |
CUGBP, Elav-like family member 6 |
53 |
0.97 |
chr4_148384170_148384515 | 132.95 |
Gm13200 |
predicted gene 13200 |
24882 |
0.14 |
chr3_84305001_84305634 | 132.50 |
Trim2 |
tripartite motif-containing 2 |
80 |
0.98 |
chr10_69465650_69465829 | 132.19 |
Gm18636 |
predicted gene, 18636 |
41991 |
0.15 |
chr4_123013911_123014467 | 130.03 |
Trit1 |
tRNA isopentenyltransferase 1 |
2408 |
0.22 |
chr17_56487941_56488561 | 126.90 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
11768 |
0.14 |
chr7_19176285_19176869 | 126.55 |
Eml2 |
echinoderm microtubule associated protein like 2 |
156 |
0.88 |
chr7_25007686_25007905 | 126.06 |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
1837 |
0.21 |
chr5_149561311_149561489 | 123.70 |
Wdr95 |
WD40 repeat domain 95 |
20378 |
0.13 |
chr10_81472976_81473160 | 122.61 |
Celf5 |
CUGBP, Elav-like family member 5 |
59 |
0.92 |
chr7_4124273_4124823 | 122.30 |
Ttyh1 |
tweety family member 1 |
59 |
0.94 |
chrX_48016798_48017205 | 115.84 |
Apln |
apelin |
17852 |
0.2 |
chrX_152197718_152198295 | 115.10 |
Iqsec2 |
IQ motif and Sec7 domain 2 |
19042 |
0.17 |
chr8_86389967_86390620 | 114.20 |
Gm24490 |
predicted gene, 24490 |
97792 |
0.07 |
chr1_14513655_14513837 | 111.57 |
Eya1 |
EYA transcriptional coactivator and phosphatase 1 |
203511 |
0.02 |
chr9_36821758_36821952 | 111.22 |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
9 |
0.97 |
chr11_109961839_109961999 | 107.81 |
Gm11697 |
predicted gene 11697 |
25603 |
0.17 |
chr12_119464462_119464632 | 104.22 |
Macc1 |
metastasis associated in colon cancer 1 |
21137 |
0.24 |
chr8_55034331_55034668 | 103.89 |
Gm45264 |
predicted gene 45264 |
6098 |
0.14 |
chr12_16855975_16856342 | 103.16 |
Gm36495 |
predicted gene, 36495 |
5277 |
0.17 |
chr1_38848197_38848380 | 103.09 |
Lonrf2 |
LON peptidase N-terminal domain and ring finger 2 |
11577 |
0.16 |
chr15_44706260_44706642 | 102.60 |
Sybu |
syntabulin (syntaxin-interacting) |
41337 |
0.15 |
chr10_121765214_121765426 | 102.40 |
BC048403 |
cDNA sequence BC048403 |
14440 |
0.18 |
chr12_55939632_55939797 | 101.99 |
Gm22296 |
predicted gene, 22296 |
28791 |
0.18 |
chr17_8368558_8368730 | 101.62 |
T2 |
brachyury 2 |
3752 |
0.15 |
chr4_148384621_148385111 | 101.57 |
Gm13200 |
predicted gene 13200 |
25406 |
0.13 |
chr7_16957122_16957287 | 100.53 |
Pnmal1 |
PNMA-like 1 |
2475 |
0.14 |
chrX_94462999_94463548 | 100.19 |
AL627302.1 |
melanoma antigen family D, 4 pseudogene |
3134 |
0.16 |
chr12_29882839_29883206 | 98.38 |
Myt1l |
myelin transcription factor 1-like |
12092 |
0.26 |
chr3_80207227_80207391 | 97.93 |
Gm37892 |
predicted gene, 37892 |
1711 |
0.39 |
chr1_17838506_17838690 | 96.38 |
Gm28153 |
predicted gene 28153 |
33181 |
0.18 |
chr6_115126272_115126705 | 96.36 |
Gm17733 |
predicted gene, 17733 |
8347 |
0.14 |
chr6_112838948_112839257 | 94.95 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
9643 |
0.23 |
chr11_32027726_32027935 | 94.77 |
Nsg2 |
neuron specific gene family member 2 |
27328 |
0.17 |
chr11_6605980_6606178 | 93.52 |
Nacad |
NAC alpha domain containing |
26 |
0.94 |
chr3_105530950_105531126 | 93.33 |
Gm43847 |
predicted gene 43847 |
28131 |
0.18 |
chr3_94484140_94484361 | 93.19 |
Celf3 |
CUGBP, Elav-like family member 3 |
77 |
0.93 |
chr1_172329252_172329450 | 93.15 |
Kcnj9 |
potassium inwardly-rectifying channel, subfamily J, member 9 |
33 |
0.95 |
chr7_105568905_105569419 | 92.36 |
Apbb1 |
amyloid beta (A4) precursor protein-binding, family B, member 1 |
103 |
0.94 |
chr2_164964516_164964914 | 91.84 |
Slc12a5 |
solute carrier family 12, member 5 |
3268 |
0.16 |
chr12_28859847_28860052 | 91.52 |
Eipr1 |
EARP complex and GARP complex interacting protein 1 |
2637 |
0.25 |
chr11_100333236_100333409 | 90.56 |
Gast |
gastrin |
1085 |
0.28 |
chr18_83399454_83399793 | 90.49 |
Gm50413 |
predicted gene, 50413 |
2 |
0.97 |
chr10_62101612_62102087 | 90.21 |
Fam241b |
family with sequence similarity 241, member B |
8647 |
0.17 |
chr12_52699206_52699547 | 89.97 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
7 |
0.98 |
chr15_30457525_30457710 | 89.32 |
Ctnnd2 |
catenin (cadherin associated protein), delta 2 |
56 |
0.98 |
chr3_25807640_25807830 | 89.23 |
Gm6197 |
predicted gene 6197 |
76492 |
0.12 |
chr8_54975613_54975775 | 89.20 |
Gm45263 |
predicted gene 45263 |
15875 |
0.14 |
chr10_9393350_9393514 | 88.44 |
Gm48750 |
predicted gene, 48750 |
37277 |
0.14 |
chr1_66386801_66386993 | 88.04 |
Map2 |
microtubule-associated protein 2 |
48 |
0.98 |
chr6_89334016_89334618 | 87.65 |
Plxna1 |
plexin A1 |
1247 |
0.4 |
chr15_74536296_74536857 | 87.37 |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
3821 |
0.22 |
chrX_94449929_94450346 | 87.12 |
Gm24595 |
predicted gene, 24595 |
4982 |
0.13 |
chr1_84621371_84621573 | 85.86 |
Dner |
delta/notch-like EGF repeat containing |
2369 |
0.33 |
chr16_18213372_18214066 | 85.75 |
4930483P17Rik |
RIKEN cDNA 4930483P17 gene |
70 |
0.59 |
chr8_103623894_103624074 | 85.46 |
4933400L20Rik |
RIKEN cDNA 4933400L20 gene |
20185 |
0.25 |
chr2_70113928_70114305 | 85.38 |
Myo3b |
myosin IIIB |
17818 |
0.23 |
chr18_34982740_34983014 | 85.24 |
Gm36037 |
predicted gene, 36037 |
45 |
0.96 |
chr10_34316810_34317259 | 85.18 |
Nt5dc1 |
5'-nucleotidase domain containing 1 |
3351 |
0.16 |
chr18_12026142_12026347 | 85.18 |
Tmem241 |
transmembrane protein 241 |
48387 |
0.14 |
chr13_107541711_107541900 | 85.18 |
Gm32004 |
predicted gene, 32004 |
23518 |
0.2 |
chr5_28859999_28860351 | 84.99 |
Gm43161 |
predicted gene 43161 |
282902 |
0.01 |
chr8_36142717_36143227 | 84.79 |
Gm38414 |
predicted gene, 38414 |
13038 |
0.15 |
chr16_37487298_37487478 | 84.69 |
Gtf2e1 |
general transcription factor II E, polypeptide 1 (alpha subunit) |
52388 |
0.11 |
chr12_29822313_29822579 | 84.35 |
Myt1l |
myelin transcription factor 1-like |
17764 |
0.27 |
chr15_25019454_25019630 | 84.20 |
Gm2824 |
predicted gene 2824 |
1148 |
0.6 |
chr7_46422473_46422673 | 84.19 |
Kcnc1 |
potassium voltage gated channel, Shaw-related subfamily, member 1 |
107 |
0.96 |
chr12_105455171_105455575 | 83.78 |
D430019H16Rik |
RIKEN cDNA D430019H16 gene |
1517 |
0.38 |
chr8_10198296_10198467 | 83.36 |
Myo16 |
myosin XVI |
44413 |
0.17 |
chrX_7919356_7919986 | 83.24 |
Pcsk1n |
proprotein convertase subtilisin/kexin type 1 inhibitor |
151 |
0.88 |
chrX_136590526_136590913 | 83.11 |
Tceal3 |
transcription elongation factor A (SII)-like 3 |
123 |
0.94 |
chr12_116677727_116678076 | 82.74 |
Gm17807 |
predicted gene, 17807 |
80648 |
0.09 |
chr5_70843183_70843368 | 82.68 |
Gabrg1 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 1 |
658 |
0.83 |
chr7_18950998_18951210 | 82.52 |
Nova2 |
NOVA alternative splicing regulator 2 |
25216 |
0.07 |
chr14_14960173_14960363 | 82.41 |
Nek10 |
NIMA (never in mitosis gene a)- related kinase 10 |
29693 |
0.19 |
chr2_129909072_129909728 | 82.17 |
Gm28196 |
predicted gene 28196 |
39168 |
0.15 |
chr1_175385720_175385916 | 82.00 |
5730408A14Rik |
RIKEN cDNA 5730408A14 gene |
5142 |
0.31 |
chr18_61845252_61845442 | 81.91 |
Afap1l1 |
actin filament associated protein 1-like 1 |
58645 |
0.1 |
chr13_59041486_59041671 | 81.87 |
Gm34245 |
predicted gene, 34245 |
36718 |
0.15 |
chr15_88978956_88979127 | 81.78 |
Mlc1 |
megalencephalic leukoencephalopathy with subcortical cysts 1 homolog (human) |
34 |
0.95 |
chr17_79550311_79550635 | 81.75 |
Rmdn2 |
regulator of microtubule dynamics 2 |
61390 |
0.13 |
chr10_60115666_60116069 | 81.65 |
Spock2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 2 |
9399 |
0.18 |
chr6_58933205_58933509 | 81.62 |
Herc3 |
hect domain and RLD 3 |
26095 |
0.12 |
chr12_116710848_116710999 | 81.52 |
Gm17807 |
predicted gene, 17807 |
113670 |
0.06 |
chr2_152654225_152654419 | 81.50 |
1700030C14Rik |
RIKEN cDNA 1700030C14 gene |
8 |
0.95 |
chr12_29528033_29528231 | 81.36 |
Myt1l |
myelin transcription factor 1-like |
252 |
0.93 |
chr13_83655223_83655396 | 81.26 |
Mef2c |
myocyte enhancer factor 2C |
2421 |
0.29 |
chr1_77545867_77546042 | 80.96 |
Gm28385 |
predicted gene 28385 |
24718 |
0.17 |
chr1_165075654_165075860 | 80.78 |
4930568G15Rik |
RIKEN cDNA 4930568G15 gene |
7643 |
0.19 |
chr3_108536548_108536875 | 80.75 |
5330417C22Rik |
RIKEN cDNA 5330417C22 gene |
175 |
0.81 |
chr5_112371951_112372551 | 80.68 |
Gm43758 |
predicted gene 43758 |
700 |
0.47 |
chr19_37991948_37992143 | 80.45 |
Myof |
myoferlin |
24919 |
0.16 |
chr18_56288011_56288179 | 80.30 |
Gm50385 |
predicted gene, 50385 |
3243 |
0.3 |
chr15_24567016_24567356 | 79.90 |
Gm48920 |
predicted gene, 48920 |
38292 |
0.19 |
chr12_70367690_70367891 | 79.79 |
Trim9 |
tripartite motif-containing 9 |
20176 |
0.17 |
chr14_24841794_24842145 | 79.36 |
Gm47906 |
predicted gene, 47906 |
8334 |
0.26 |
chr19_22189818_22189969 | 79.32 |
Gm22506 |
predicted gene, 22506 |
45725 |
0.16 |
chr1_93115079_93115394 | 79.30 |
Gm28086 |
predicted gene 28086 |
8867 |
0.13 |
chr10_38555193_38555395 | 79.18 |
Gm22911 |
predicted gene, 22911 |
60187 |
0.15 |
chr14_65404115_65404582 | 79.12 |
Zfp395 |
zinc finger protein 395 |
8668 |
0.19 |
chr14_20048215_20048379 | 79.11 |
Gm48339 |
predicted gene, 48339 |
10000 |
0.19 |
chr2_66177940_66178130 | 78.86 |
Gm13618 |
predicted gene 13618 |
9801 |
0.18 |
chr11_80622777_80622948 | 78.72 |
C030013C21Rik |
RIKEN cDNA C030013C21 gene |
113756 |
0.05 |
chr5_30763259_30763446 | 78.72 |
Gm42764 |
predicted gene 42764 |
4320 |
0.15 |
chr18_32117668_32117861 | 78.57 |
4933435E02Rik |
RIKEN cDNA 4933435E02 gene |
1019 |
0.38 |
chr9_50138688_50138839 | 78.55 |
Gm8907 |
predicted gene 8907 |
48282 |
0.15 |
chr3_107038802_107038996 | 78.21 |
AI504432 |
expressed sequence AI504432 |
605 |
0.68 |
chr3_52062201_52062354 | 77.72 |
C130089K02Rik |
RIKEN cDNA C130089K02 gene |
1967 |
0.25 |
chr2_152375831_152376029 | 77.68 |
Nrsn2 |
neurensin 2 |
708 |
0.41 |
chrX_135957411_135957579 | 77.30 |
Gm15016 |
predicted gene 15016 |
31052 |
0.12 |
chr6_82609430_82609610 | 77.01 |
Pole4 |
polymerase (DNA-directed), epsilon 4 (p12 subunit) |
42998 |
0.15 |
chr4_138598114_138598322 | 76.75 |
Vwa5b1 |
von Willebrand factor A domain containing 5B1 |
8312 |
0.19 |
chr2_102337010_102337185 | 76.69 |
Gm13868 |
predicted gene 13868 |
24890 |
0.21 |
chr2_157049785_157050310 | 76.63 |
Soga1 |
suppressor of glucose, autophagy associated 1 |
9808 |
0.14 |
chr3_55373721_55374118 | 76.41 |
Dclk1 |
doublecortin-like kinase 1 |
19785 |
0.15 |
chr9_44457408_44457744 | 76.26 |
Upk2 |
uroplakin 2 |
2600 |
0.09 |
chr2_33543245_33543667 | 76.26 |
Gm13530 |
predicted gene 13530 |
53674 |
0.1 |
chr15_39775617_39775890 | 76.18 |
Dpys |
dihydropyrimidinase |
17498 |
0.18 |
chr6_17968861_17969012 | 76.07 |
Gm43844 |
predicted gene 43844 |
53940 |
0.11 |
chr13_34088829_34089019 | 76.01 |
Gm47065 |
predicted gene, 47065 |
103 |
0.94 |
chr5_137734345_137734665 | 75.88 |
Nyap1 |
neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 1 |
5213 |
0.09 |
chr13_34575963_34576208 | 75.87 |
Gm36758 |
predicted gene, 36758 |
14099 |
0.16 |
chr3_81830305_81830493 | 75.63 |
A830029E22Rik |
RIKEN cDNA A830029E22 gene |
28374 |
0.18 |
chrX_136290785_136291013 | 75.56 |
n-R5s12 |
nuclear encoded rRNA 5S 12 |
13394 |
0.09 |
chr2_164964299_164964474 | 75.51 |
Slc12a5 |
solute carrier family 12, member 5 |
3540 |
0.16 |
chr15_72851806_72852015 | 75.50 |
Peg13 |
paternally expressed 13 |
41586 |
0.16 |
chr16_42269380_42269583 | 75.47 |
Gap43 |
growth associated protein 43 |
6591 |
0.24 |
chr9_39557872_39558050 | 75.46 |
Olfr958 |
olfactory receptor 958 |
3907 |
0.12 |
chr1_166280678_166280860 | 75.31 |
Ildr2 |
immunoglobulin-like domain containing receptor 2 |
26576 |
0.14 |
chr7_62261961_62262132 | 74.83 |
Gm9801 |
predicted gene 9801 |
52567 |
0.13 |
chr4_48924626_48925013 | 74.79 |
Gm12436 |
predicted gene 12436 |
26226 |
0.17 |
chr5_103160967_103161542 | 74.57 |
Mapk10 |
mitogen-activated protein kinase 10 |
44675 |
0.17 |
chr6_91284798_91284980 | 74.51 |
Fbln2 |
fibulin 2 |
19010 |
0.17 |
chr6_50777261_50777465 | 74.51 |
C530044C16Rik |
RIKEN cDNA C530044C16 gene |
1039 |
0.49 |
chr16_5992138_5992346 | 74.45 |
1700123O21Rik |
RIKEN cDNA 1700123O21 gene |
16657 |
0.29 |
chr5_149317066_149317217 | 74.25 |
Gm19719 |
predicted gene, 19719 |
29273 |
0.09 |
chr11_68215228_68215632 | 74.22 |
Mir6406 |
microRNA 6406 |
5462 |
0.21 |
chr13_51580731_51580926 | 74.16 |
Shc3 |
src homology 2 domain-containing transforming protein C3 |
11341 |
0.21 |
chr1_54578686_54578939 | 73.94 |
Gm19637 |
predicted gene, 19637 |
12109 |
0.18 |
chr12_44371185_44371336 | 73.82 |
Gm48181 |
predicted gene, 48181 |
1937 |
0.32 |
chr9_17485129_17485436 | 73.76 |
Gm2594 |
predicted gene 2594 |
17427 |
0.24 |
chr8_13705749_13705921 | 73.57 |
Cfap97d2 |
CFAP97 domain containing 2 |
54 |
0.97 |
chr3_56962631_56962829 | 73.53 |
Gm22269 |
predicted gene, 22269 |
91420 |
0.09 |
chr15_59041104_59041326 | 73.51 |
Mtss1 |
MTSS I-BAR domain containing 1 |
618 |
0.77 |
chr1_79598887_79599093 | 73.43 |
Gm37886 |
predicted gene, 37886 |
22044 |
0.2 |
chr2_151949459_151949610 | 73.41 |
Gm14154 |
predicted gene 14154 |
1107 |
0.4 |
chr3_97522408_97522593 | 73.37 |
Chd1l |
chromodomain helicase DNA binding protein 1-like |
44612 |
0.14 |
chr12_80061788_80062584 | 73.32 |
Gm36660 |
predicted gene, 36660 |
19248 |
0.14 |
chr14_63699229_63699409 | 73.31 |
Mir598 |
microRNA 598 |
27870 |
0.17 |
chr3_133244103_133244381 | 73.24 |
Arhgef38 |
Rho guanine nucleotide exchange factor (GEF) 38 |
9293 |
0.22 |
chr7_16959475_16959821 | 73.08 |
Pnmal1 |
PNMA-like 1 |
31 |
0.95 |
chr14_124669751_124670093 | 73.02 |
Fgf14 |
fibroblast growth factor 14 |
7205 |
0.25 |
chr9_21197538_21198329 | 72.94 |
Pde4a |
phosphodiesterase 4A, cAMP specific |
1228 |
0.29 |
chr4_130865879_130866098 | 72.86 |
Gm22660 |
predicted gene, 22660 |
8108 |
0.15 |
chr8_70089674_70089889 | 72.80 |
Hapln4 |
hyaluronan and proteoglycan link protein 4 |
5637 |
0.09 |
chr1_74858050_74858726 | 72.70 |
Cdk5r2 |
cyclin-dependent kinase 5, regulatory subunit 2 (p39) |
3454 |
0.13 |
chr7_46454115_46454303 | 72.64 |
Gm22969 |
predicted gene, 22969 |
3796 |
0.2 |
chr2_43208323_43208495 | 72.58 |
Gm13464 |
predicted gene 13464 |
310989 |
0.01 |
chr3_107411821_107412029 | 72.51 |
Kcnc4 |
potassium voltage gated channel, Shaw-related subfamily, member 4 |
47627 |
0.11 |
chr15_12365691_12366546 | 72.45 |
1810049J17Rik |
RIKEN cDNA 1810049J17 gene |
44219 |
0.12 |
chr15_36967359_36968246 | 72.27 |
Gm34590 |
predicted gene, 34590 |
28938 |
0.13 |
chr9_105343064_105343249 | 72.02 |
Gm15619 |
predicted gene 15619 |
9643 |
0.19 |
chr7_100307827_100308183 | 71.93 |
P4ha3 |
procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha polypeptide III |
6424 |
0.15 |
chr6_54785459_54785618 | 71.90 |
Znrf2 |
zinc and ring finger 2 |
31378 |
0.17 |
chr2_168678724_168679270 | 71.73 |
Atp9a |
ATPase, class II, type 9A |
8651 |
0.21 |
chr18_22850734_22850918 | 71.72 |
Nol4 |
nucleolar protein 4 |
72 |
0.99 |
chr1_132858883_132859082 | 71.67 |
Lrrn2 |
leucine rich repeat protein 2, neuronal |
21291 |
0.17 |
chr4_142957157_142957348 | 71.66 |
6330411D24Rik |
RIKEN cDNA 6330411D24 gene |
116514 |
0.06 |
chr3_79867193_79867402 | 71.66 |
Tmem144 |
transmembrane protein 144 |
14524 |
0.15 |
chr3_55521858_55522061 | 71.63 |
Gm42608 |
predicted gene 42608 |
4390 |
0.16 |
chr2_83941079_83941335 | 71.45 |
Zswim2 |
zinc finger SWIM-type containing 2 |
19 |
0.96 |
chr15_24877836_24878003 | 71.39 |
Gm35769 |
predicted gene, 35769 |
29289 |
0.2 |
chr14_24262681_24263296 | 71.38 |
Dlg5 |
discs large MAGUK scaffold protein 5 |
17068 |
0.1 |
chr3_33024670_33024835 | 71.29 |
4930419G24Rik |
RIKEN cDNA 4930419G24 gene |
25 |
0.97 |
chr1_135565049_135565423 | 71.10 |
Gm4793 |
predicted gene 4793 |
19537 |
0.15 |
chr12_89148877_89149466 | 70.94 |
Nrxn3 |
neurexin III |
43935 |
0.19 |
chr1_42540124_42540492 | 70.73 |
Gm37047 |
predicted gene, 37047 |
48495 |
0.15 |
chr7_78882402_78882885 | 70.68 |
Mir7-2 |
microRNA 7-2 |
5634 |
0.12 |
chr7_6851826_6852008 | 70.58 |
Gm44586 |
predicted gene 44586 |
39121 |
0.09 |
chr11_32113166_32113503 | 70.44 |
Gm12108 |
predicted gene 12108 |
12106 |
0.19 |
chr2_167201812_167202025 | 69.98 |
Gm14291 |
predicted gene 14291 |
342 |
0.82 |
chr1_84585391_84585851 | 69.83 |
Dner |
delta/notch-like EGF repeat containing |
38220 |
0.17 |
chr8_69832079_69833191 | 69.76 |
Pbx4 |
pre B cell leukemia homeobox 4 |
2 |
0.96 |
chr6_114290246_114290556 | 69.41 |
Slc6a1 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 |
7611 |
0.27 |
chr17_7366746_7366975 | 69.19 |
Gm49630 |
predicted gene, 49630 |
5119 |
0.14 |
chr8_94567212_94567395 | 69.13 |
Cpne2 |
copine II |
4653 |
0.14 |
chr14_31268447_31269032 | 69.03 |
Gm35823 |
predicted gene, 35823 |
18 |
0.92 |
chr6_37643932_37644157 | 68.94 |
Ybx1-ps2 |
Y box protein 1, pseudogene 2 |
43151 |
0.17 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
28.6 | 400.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
26.8 | 347.8 | GO:0071625 | vocalization behavior(GO:0071625) |
24.6 | 49.2 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
24.3 | 97.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
21.9 | 87.6 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
19.9 | 59.8 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
17.6 | 70.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
17.2 | 17.2 | GO:0021586 | pons maturation(GO:0021586) |
16.6 | 66.5 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
16.6 | 66.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
16.4 | 49.1 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
15.7 | 62.7 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
14.6 | 43.8 | GO:0030035 | microspike assembly(GO:0030035) |
13.7 | 68.5 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
13.6 | 122.4 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
13.4 | 53.7 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
13.4 | 40.3 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
12.9 | 38.7 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
12.8 | 89.3 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
12.3 | 36.8 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
12.0 | 72.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
11.8 | 118.3 | GO:0032026 | response to magnesium ion(GO:0032026) |
11.3 | 124.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
11.1 | 33.4 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
11.0 | 22.0 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
11.0 | 33.0 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
10.9 | 32.8 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
10.6 | 31.8 | GO:0021564 | vagus nerve development(GO:0021564) |
10.6 | 31.7 | GO:0046098 | guanine metabolic process(GO:0046098) |
10.1 | 50.6 | GO:0071918 | urea transmembrane transport(GO:0071918) |
9.8 | 49.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
9.7 | 29.2 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
9.5 | 19.1 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
9.4 | 141.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
9.4 | 9.4 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
9.4 | 28.1 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
9.3 | 65.3 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
9.3 | 139.1 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
9.2 | 27.7 | GO:0071492 | cellular response to UV-A(GO:0071492) |
9.2 | 82.9 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
8.8 | 35.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
8.8 | 17.6 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
8.7 | 26.0 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
8.6 | 34.5 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
8.6 | 77.5 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
8.5 | 42.7 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
8.5 | 59.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
8.5 | 68.0 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
8.5 | 25.4 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
8.4 | 42.1 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
8.4 | 25.1 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
8.4 | 67.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
8.3 | 41.7 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
8.2 | 49.2 | GO:0016198 | axon choice point recognition(GO:0016198) |
8.1 | 16.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
8.1 | 24.3 | GO:0035524 | proline transmembrane transport(GO:0035524) |
8.1 | 40.4 | GO:0032252 | secretory granule localization(GO:0032252) |
8.0 | 16.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
8.0 | 32.0 | GO:0022038 | corpus callosum development(GO:0022038) |
7.9 | 63.2 | GO:0050957 | equilibrioception(GO:0050957) |
7.8 | 39.2 | GO:0014028 | notochord formation(GO:0014028) |
7.8 | 38.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
7.6 | 22.7 | GO:0001927 | exocyst assembly(GO:0001927) |
7.6 | 68.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
7.5 | 22.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
7.5 | 22.6 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
7.5 | 15.0 | GO:0007525 | somatic muscle development(GO:0007525) |
7.5 | 22.4 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
7.4 | 29.7 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
7.4 | 7.4 | GO:0072221 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
7.3 | 22.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
7.3 | 36.4 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
7.2 | 86.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
7.2 | 7.2 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
7.1 | 14.3 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
7.0 | 118.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
7.0 | 20.9 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
6.9 | 83.1 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
6.9 | 41.4 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
6.8 | 34.1 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
6.8 | 6.8 | GO:0043622 | cortical microtubule organization(GO:0043622) |
6.8 | 20.3 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
6.7 | 20.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
6.7 | 20.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
6.6 | 288.8 | GO:0046847 | filopodium assembly(GO:0046847) |
6.6 | 26.2 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
6.6 | 104.9 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
6.5 | 19.6 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
6.4 | 25.8 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
6.4 | 12.9 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
6.4 | 19.2 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
6.4 | 25.6 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
6.4 | 31.8 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
6.2 | 37.1 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
6.2 | 18.5 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
6.1 | 12.2 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
6.1 | 18.3 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
6.0 | 12.0 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
6.0 | 18.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
6.0 | 17.9 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
6.0 | 161.2 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
6.0 | 6.0 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
5.9 | 17.6 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
5.8 | 5.8 | GO:0003096 | renal sodium ion transport(GO:0003096) |
5.8 | 51.8 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
5.7 | 17.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
5.6 | 11.3 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
5.6 | 16.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
5.5 | 16.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
5.5 | 49.5 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
5.5 | 11.0 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
5.4 | 5.4 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
5.4 | 101.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
5.4 | 48.2 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
5.3 | 132.8 | GO:0010107 | potassium ion import(GO:0010107) |
5.3 | 31.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
5.3 | 47.4 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
5.3 | 15.8 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
5.2 | 15.7 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
5.2 | 5.2 | GO:0034204 | lipid translocation(GO:0034204) |
5.2 | 5.2 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
5.1 | 5.1 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
5.1 | 10.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
5.1 | 15.2 | GO:0002930 | trabecular meshwork development(GO:0002930) |
5.0 | 15.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
4.9 | 9.9 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
4.9 | 14.8 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
4.9 | 19.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
4.9 | 14.7 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
4.9 | 14.6 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
4.8 | 9.7 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
4.8 | 4.8 | GO:1903375 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
4.8 | 19.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
4.8 | 19.1 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
4.8 | 19.1 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
4.8 | 9.5 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
4.7 | 14.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
4.6 | 18.6 | GO:0044838 | cell quiescence(GO:0044838) |
4.6 | 9.3 | GO:0072679 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
4.6 | 13.9 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
4.6 | 4.6 | GO:0032898 | neurotrophin production(GO:0032898) |
4.6 | 13.8 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
4.6 | 23.0 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
4.6 | 9.2 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
4.6 | 18.3 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
4.5 | 27.2 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
4.5 | 13.6 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
4.5 | 44.8 | GO:0008038 | neuron recognition(GO:0008038) |
4.5 | 13.4 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
4.5 | 22.3 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
4.4 | 13.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
4.4 | 30.7 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
4.4 | 13.1 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
4.3 | 13.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
4.3 | 12.9 | GO:0040016 | embryonic cleavage(GO:0040016) |
4.3 | 4.3 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
4.3 | 25.6 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
4.3 | 72.5 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
4.2 | 25.5 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
4.2 | 33.9 | GO:0017121 | phospholipid scrambling(GO:0017121) |
4.2 | 12.7 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
4.2 | 4.2 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
4.2 | 33.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
4.2 | 63.1 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
4.2 | 29.4 | GO:0060736 | prostate gland growth(GO:0060736) |
4.2 | 12.5 | GO:0015791 | polyol transport(GO:0015791) |
4.1 | 12.4 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
4.1 | 12.3 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
4.1 | 12.2 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
4.1 | 12.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
4.1 | 4.1 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
4.1 | 12.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
4.0 | 8.1 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
4.0 | 12.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
4.0 | 16.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
4.0 | 16.2 | GO:0003091 | renal water homeostasis(GO:0003091) |
4.0 | 16.1 | GO:0046102 | inosine metabolic process(GO:0046102) |
4.0 | 36.0 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
4.0 | 15.9 | GO:0071435 | potassium ion export(GO:0071435) |
4.0 | 23.9 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
4.0 | 31.8 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
4.0 | 8.0 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
4.0 | 11.9 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
4.0 | 31.6 | GO:0032570 | response to progesterone(GO:0032570) |
4.0 | 15.8 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
3.9 | 11.7 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
3.9 | 7.8 | GO:0032672 | regulation of interleukin-3 production(GO:0032672) |
3.9 | 11.6 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
3.8 | 184.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
3.8 | 15.3 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
3.8 | 7.6 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
3.8 | 11.4 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
3.8 | 15.2 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
3.8 | 45.5 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
3.8 | 15.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
3.8 | 15.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
3.8 | 7.5 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
3.8 | 116.3 | GO:0021954 | central nervous system neuron development(GO:0021954) |
3.7 | 18.7 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
3.7 | 11.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
3.7 | 18.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
3.6 | 36.5 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
3.6 | 10.9 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
3.6 | 54.6 | GO:0002335 | mature B cell differentiation(GO:0002335) |
3.6 | 10.9 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
3.6 | 7.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
3.6 | 3.6 | GO:0043133 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
3.6 | 21.6 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
3.6 | 10.8 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
3.6 | 14.3 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
3.6 | 10.7 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
3.5 | 3.5 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
3.5 | 10.6 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
3.5 | 7.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
3.5 | 10.6 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
3.5 | 7.0 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
3.5 | 7.0 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
3.5 | 136.6 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
3.5 | 20.9 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
3.5 | 7.0 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
3.5 | 3.5 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
3.4 | 23.9 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
3.4 | 13.6 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
3.4 | 3.4 | GO:0071314 | cellular response to cocaine(GO:0071314) |
3.4 | 6.7 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
3.4 | 6.7 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
3.3 | 3.3 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
3.3 | 16.7 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
3.3 | 113.4 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
3.3 | 3.3 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
3.3 | 13.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
3.3 | 9.8 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
3.2 | 120.0 | GO:0008542 | visual learning(GO:0008542) |
3.2 | 9.7 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
3.2 | 3.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
3.2 | 12.8 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
3.2 | 9.6 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
3.2 | 12.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
3.2 | 9.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
3.1 | 15.7 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
3.1 | 3.1 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
3.1 | 47.1 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
3.1 | 12.4 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
3.1 | 3.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
3.1 | 18.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
3.1 | 15.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
3.1 | 6.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
3.1 | 12.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
3.0 | 18.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
3.0 | 6.1 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
3.0 | 3.0 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
3.0 | 6.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
3.0 | 77.8 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
3.0 | 6.0 | GO:0006971 | hypotonic response(GO:0006971) |
3.0 | 8.9 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
3.0 | 20.7 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
2.9 | 14.7 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
2.9 | 8.8 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
2.9 | 11.7 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
2.9 | 38.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
2.9 | 5.8 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
2.9 | 8.8 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
2.9 | 55.3 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
2.9 | 5.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
2.9 | 11.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
2.9 | 11.6 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
2.9 | 37.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
2.9 | 5.7 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
2.9 | 11.4 | GO:0032824 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
2.8 | 8.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
2.8 | 39.8 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
2.8 | 5.7 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
2.8 | 14.2 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
2.8 | 8.5 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
2.8 | 2.8 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
2.8 | 14.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
2.8 | 8.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
2.8 | 50.4 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
2.8 | 5.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
2.7 | 8.2 | GO:0060174 | limb bud formation(GO:0060174) |
2.7 | 8.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
2.7 | 10.9 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
2.7 | 16.3 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
2.7 | 8.1 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
2.7 | 35.1 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
2.7 | 2.7 | GO:0015840 | urea transport(GO:0015840) |
2.7 | 2.7 | GO:1902804 | negative regulation of synaptic vesicle transport(GO:1902804) |
2.7 | 8.0 | GO:0015747 | urate transport(GO:0015747) |
2.7 | 5.4 | GO:0060134 | prepulse inhibition(GO:0060134) |
2.6 | 5.3 | GO:1903909 | regulation of receptor clustering(GO:1903909) |
2.6 | 7.9 | GO:0007638 | mechanosensory behavior(GO:0007638) |
2.6 | 23.8 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
2.6 | 7.9 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
2.6 | 5.3 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
2.6 | 10.5 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
2.6 | 13.0 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
2.6 | 15.6 | GO:0070986 | left/right axis specification(GO:0070986) |
2.6 | 7.8 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
2.6 | 36.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
2.6 | 5.2 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
2.6 | 5.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
2.6 | 5.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
2.6 | 10.2 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
2.5 | 5.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
2.5 | 40.5 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
2.5 | 27.8 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
2.5 | 30.0 | GO:0048368 | lateral mesoderm development(GO:0048368) |
2.5 | 5.0 | GO:0046061 | dATP catabolic process(GO:0046061) |
2.5 | 2.5 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
2.5 | 12.4 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
2.5 | 7.4 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
2.5 | 14.8 | GO:0006477 | protein sulfation(GO:0006477) |
2.5 | 29.6 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
2.5 | 2.5 | GO:0021747 | cochlear nucleus development(GO:0021747) |
2.4 | 9.8 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
2.4 | 51.3 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
2.4 | 2.4 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
2.4 | 7.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
2.4 | 2.4 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
2.4 | 9.6 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
2.4 | 16.8 | GO:0006108 | malate metabolic process(GO:0006108) |
2.4 | 16.8 | GO:0008105 | asymmetric protein localization(GO:0008105) |
2.4 | 2.4 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
2.4 | 21.6 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
2.4 | 2.4 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
2.4 | 9.5 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
2.4 | 14.3 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
2.4 | 9.5 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
2.4 | 4.7 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
2.4 | 7.1 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
2.3 | 9.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
2.3 | 14.1 | GO:0035640 | exploration behavior(GO:0035640) |
2.3 | 2.3 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
2.3 | 6.9 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
2.3 | 4.6 | GO:0060431 | primary lung bud formation(GO:0060431) |
2.3 | 6.9 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
2.3 | 11.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
2.3 | 13.8 | GO:0060290 | transdifferentiation(GO:0060290) |
2.3 | 6.9 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
2.3 | 6.9 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
2.3 | 9.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
2.3 | 2.3 | GO:0060463 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
2.3 | 4.5 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
2.3 | 13.6 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
2.3 | 11.3 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
2.3 | 22.5 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
2.3 | 4.5 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
2.2 | 2.2 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
2.2 | 6.6 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
2.2 | 13.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
2.2 | 6.5 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
2.2 | 21.8 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
2.2 | 13.0 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
2.2 | 6.5 | GO:0015889 | cobalamin transport(GO:0015889) |
2.2 | 6.5 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
2.2 | 2.2 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
2.2 | 15.1 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
2.1 | 2.1 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) |
2.1 | 2.1 | GO:0072179 | nephric duct formation(GO:0072179) |
2.1 | 10.6 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
2.1 | 6.3 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
2.1 | 10.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
2.1 | 12.6 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
2.1 | 2.1 | GO:0045914 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
2.1 | 18.8 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
2.1 | 14.6 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
2.1 | 8.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
2.1 | 32.9 | GO:1902668 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
2.1 | 16.4 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
2.1 | 8.2 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
2.0 | 6.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
2.0 | 20.4 | GO:0045056 | transcytosis(GO:0045056) |
2.0 | 8.1 | GO:0035627 | ceramide transport(GO:0035627) |
2.0 | 24.3 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
2.0 | 20.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
2.0 | 6.1 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
2.0 | 8.0 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) |
2.0 | 10.0 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
2.0 | 4.0 | GO:0008050 | courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
2.0 | 2.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
2.0 | 2.0 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
2.0 | 2.0 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
2.0 | 39.5 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
2.0 | 173.8 | GO:0010921 | regulation of phosphatase activity(GO:0010921) |
2.0 | 3.9 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
2.0 | 2.0 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
2.0 | 5.9 | GO:0033622 | integrin activation(GO:0033622) |
2.0 | 3.9 | GO:0090148 | membrane fission(GO:0090148) |
2.0 | 9.8 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
2.0 | 2.0 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
2.0 | 44.9 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
1.9 | 23.4 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
1.9 | 3.9 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
1.9 | 5.8 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
1.9 | 11.5 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
1.9 | 11.4 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
1.9 | 15.2 | GO:0007616 | long-term memory(GO:0007616) |
1.9 | 3.8 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
1.9 | 9.5 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
1.9 | 102.6 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
1.9 | 1.9 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
1.9 | 7.6 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
1.9 | 13.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
1.9 | 7.5 | GO:0060074 | synapse maturation(GO:0060074) |
1.9 | 5.6 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
1.9 | 3.8 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.9 | 11.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
1.9 | 9.4 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
1.9 | 3.7 | GO:0046952 | ketone body catabolic process(GO:0046952) |
1.9 | 13.1 | GO:0006265 | DNA topological change(GO:0006265) |
1.9 | 7.5 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
1.9 | 11.2 | GO:0001964 | startle response(GO:0001964) |
1.9 | 5.6 | GO:0032202 | telomere assembly(GO:0032202) |
1.8 | 12.9 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
1.8 | 1.8 | GO:2000510 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
1.8 | 5.5 | GO:0021570 | rhombomere 4 development(GO:0021570) |
1.8 | 7.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
1.8 | 12.8 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
1.8 | 5.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.8 | 7.3 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
1.8 | 3.6 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
1.8 | 3.6 | GO:0072176 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
1.8 | 5.4 | GO:0001975 | response to amphetamine(GO:0001975) |
1.8 | 10.8 | GO:0060346 | bone trabecula formation(GO:0060346) |
1.8 | 7.2 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
1.8 | 39.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
1.8 | 12.6 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
1.8 | 1.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.8 | 5.4 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
1.8 | 3.6 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
1.8 | 3.6 | GO:1903011 | negative regulation of bone development(GO:1903011) |
1.8 | 3.5 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
1.8 | 3.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
1.8 | 3.5 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
1.7 | 17.5 | GO:0051904 | melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
1.7 | 3.5 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
1.7 | 7.0 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
1.7 | 34.5 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
1.7 | 12.1 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
1.7 | 3.4 | GO:0042940 | D-amino acid transport(GO:0042940) |
1.7 | 3.4 | GO:0016237 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
1.7 | 5.1 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
1.7 | 1.7 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
1.7 | 1.7 | GO:0061511 | centriole elongation(GO:0061511) |
1.7 | 8.5 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
1.7 | 15.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
1.7 | 1.7 | GO:0014075 | response to amine(GO:0014075) |
1.7 | 5.1 | GO:2001273 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
1.7 | 5.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
1.7 | 6.7 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
1.7 | 11.7 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
1.7 | 5.0 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
1.7 | 3.3 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
1.7 | 3.3 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
1.7 | 3.3 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
1.7 | 6.7 | GO:0046689 | response to mercury ion(GO:0046689) |
1.7 | 8.3 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
1.7 | 13.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
1.7 | 9.9 | GO:0048102 | autophagic cell death(GO:0048102) |
1.6 | 4.9 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.6 | 4.9 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
1.6 | 16.4 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
1.6 | 6.5 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
1.6 | 3.3 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
1.6 | 14.7 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
1.6 | 3.2 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
1.6 | 3.2 | GO:0072143 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) pericyte cell differentiation(GO:1904238) |
1.6 | 6.5 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
1.6 | 4.8 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
1.6 | 6.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
1.6 | 4.8 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
1.6 | 6.4 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
1.6 | 4.8 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
1.6 | 1.6 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
1.6 | 9.6 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
1.6 | 4.8 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
1.6 | 3.2 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
1.6 | 8.0 | GO:0035307 | positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
1.6 | 44.6 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
1.6 | 3.2 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
1.6 | 1.6 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
1.6 | 3.2 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
1.6 | 7.9 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
1.6 | 3.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
1.6 | 3.1 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
1.6 | 1.6 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
1.6 | 4.7 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
1.6 | 3.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.5 | 3.1 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
1.5 | 7.7 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
1.5 | 7.7 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
1.5 | 1.5 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
1.5 | 4.6 | GO:0007296 | vitellogenesis(GO:0007296) |
1.5 | 1.5 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
1.5 | 4.6 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
1.5 | 6.1 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
1.5 | 4.6 | GO:0048014 | Tie signaling pathway(GO:0048014) |
1.5 | 7.6 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
1.5 | 24.3 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
1.5 | 9.0 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
1.5 | 4.5 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
1.5 | 49.0 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
1.5 | 7.4 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
1.5 | 5.9 | GO:0042256 | mature ribosome assembly(GO:0042256) |
1.5 | 4.4 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.5 | 5.9 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
1.5 | 11.8 | GO:0021983 | pituitary gland development(GO:0021983) |
1.5 | 7.4 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
1.5 | 4.4 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
1.5 | 10.3 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
1.5 | 8.8 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
1.5 | 2.9 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
1.5 | 4.4 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
1.5 | 53.7 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
1.4 | 10.1 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
1.4 | 4.3 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
1.4 | 1.4 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
1.4 | 8.7 | GO:0006013 | mannose metabolic process(GO:0006013) |
1.4 | 11.5 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
1.4 | 4.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
1.4 | 1.4 | GO:0007494 | midgut development(GO:0007494) |
1.4 | 2.9 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
1.4 | 2.8 | GO:0090135 | actin filament branching(GO:0090135) |
1.4 | 25.6 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
1.4 | 11.3 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
1.4 | 22.6 | GO:0050905 | neuromuscular process(GO:0050905) |
1.4 | 9.9 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
1.4 | 1.4 | GO:2000551 | regulation of T-helper 2 cell cytokine production(GO:2000551) |
1.4 | 4.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
1.4 | 5.6 | GO:0070307 | lens fiber cell development(GO:0070307) |
1.4 | 4.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
1.4 | 5.6 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
1.4 | 2.8 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
1.4 | 1.4 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
1.4 | 8.3 | GO:0016322 | neuron remodeling(GO:0016322) |
1.4 | 4.2 | GO:0031296 | B cell costimulation(GO:0031296) |
1.4 | 5.5 | GO:0035315 | hair cell differentiation(GO:0035315) |
1.4 | 2.8 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
1.4 | 1.4 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) response to glycoside(GO:1903416) |
1.4 | 1.4 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
1.4 | 5.4 | GO:0015846 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
1.4 | 4.1 | GO:0002679 | respiratory burst involved in inflammatory response(GO:0002536) respiratory burst involved in defense response(GO:0002679) regulation of respiratory burst involved in inflammatory response(GO:0060264) |
1.4 | 4.1 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
1.4 | 5.4 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
1.3 | 4.0 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
1.3 | 1.3 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
1.3 | 1.3 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
1.3 | 1.3 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
1.3 | 13.3 | GO:0043248 | proteasome assembly(GO:0043248) |
1.3 | 1.3 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
1.3 | 9.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
1.3 | 2.6 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
1.3 | 1.3 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
1.3 | 13.1 | GO:0010842 | retina layer formation(GO:0010842) |
1.3 | 3.9 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
1.3 | 10.4 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
1.3 | 1.3 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
1.3 | 1.3 | GO:0060005 | vestibular reflex(GO:0060005) |
1.3 | 3.9 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
1.3 | 6.5 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
1.3 | 7.7 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
1.3 | 60.6 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
1.3 | 2.6 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
1.3 | 6.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
1.3 | 6.4 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
1.3 | 2.5 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.3 | 14.0 | GO:0042551 | neuron maturation(GO:0042551) |
1.3 | 5.1 | GO:0034651 | cortisol biosynthetic process(GO:0034651) |
1.3 | 10.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
1.3 | 13.9 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
1.3 | 10.1 | GO:0001755 | neural crest cell migration(GO:0001755) |
1.3 | 3.8 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
1.3 | 5.0 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
1.3 | 6.3 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
1.3 | 11.3 | GO:0007625 | grooming behavior(GO:0007625) |
1.3 | 7.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
1.3 | 8.8 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
1.3 | 2.5 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
1.3 | 3.8 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
1.2 | 17.5 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
1.2 | 7.5 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
1.2 | 19.9 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
1.2 | 7.5 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
1.2 | 2.5 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
1.2 | 2.5 | GO:0042048 | olfactory behavior(GO:0042048) |
1.2 | 7.4 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
1.2 | 22.2 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
1.2 | 14.8 | GO:0030819 | positive regulation of cAMP biosynthetic process(GO:0030819) |
1.2 | 1.2 | GO:1990144 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
1.2 | 2.4 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
1.2 | 2.4 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
1.2 | 4.8 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
1.2 | 2.4 | GO:0034650 | cortisol metabolic process(GO:0034650) |
1.2 | 2.4 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
1.2 | 3.6 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
1.2 | 61.4 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
1.2 | 3.6 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
1.2 | 4.8 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
1.2 | 3.6 | GO:0060631 | regulation of meiosis I(GO:0060631) |
1.2 | 2.4 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
1.2 | 1.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
1.2 | 49.7 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
1.2 | 27.1 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
1.2 | 11.8 | GO:0003351 | epithelial cilium movement(GO:0003351) |
1.2 | 7.0 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
1.2 | 1.2 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
1.2 | 5.9 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
1.2 | 3.5 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
1.2 | 2.3 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.2 | 4.6 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
1.2 | 4.6 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
1.2 | 1.2 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
1.2 | 3.5 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
1.2 | 6.9 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
1.1 | 2.3 | GO:0060618 | nipple development(GO:0060618) |
1.1 | 8.0 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
1.1 | 19.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
1.1 | 55.5 | GO:0007188 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway(GO:0007188) |
1.1 | 6.8 | GO:0015825 | L-serine transport(GO:0015825) serine transport(GO:0032329) |
1.1 | 21.4 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
1.1 | 22.5 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
1.1 | 1.1 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
1.1 | 4.5 | GO:0030091 | protein repair(GO:0030091) |
1.1 | 1.1 | GO:0060459 | left lung development(GO:0060459) |
1.1 | 4.5 | GO:0009651 | response to salt stress(GO:0009651) |
1.1 | 3.4 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
1.1 | 4.5 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
1.1 | 3.3 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
1.1 | 10.0 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
1.1 | 2.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
1.1 | 3.3 | GO:0048854 | brain morphogenesis(GO:0048854) |
1.1 | 12.2 | GO:0042407 | cristae formation(GO:0042407) |
1.1 | 7.7 | GO:0098926 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
1.1 | 3.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
1.1 | 5.5 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
1.1 | 4.4 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.1 | 16.5 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
1.1 | 1.1 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
1.1 | 4.4 | GO:1904385 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
1.1 | 7.6 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
1.1 | 17.4 | GO:0046834 | lipid phosphorylation(GO:0046834) |
1.1 | 3.3 | GO:0031017 | exocrine pancreas development(GO:0031017) |
1.1 | 14.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
1.1 | 46.6 | GO:0006334 | nucleosome assembly(GO:0006334) |
1.1 | 2.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.1 | 4.3 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
1.1 | 1.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
1.1 | 4.3 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
1.1 | 2.1 | GO:0070253 | somatostatin secretion(GO:0070253) |
1.1 | 8.6 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
1.1 | 6.4 | GO:0015800 | acidic amino acid transport(GO:0015800) |
1.1 | 1.1 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
1.1 | 4.2 | GO:0015871 | choline transport(GO:0015871) |
1.1 | 1.1 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
1.0 | 7.3 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) |
1.0 | 48.3 | GO:0006400 | tRNA modification(GO:0006400) |
1.0 | 3.1 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
1.0 | 42.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
1.0 | 1.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
1.0 | 3.1 | GO:0019348 | dolichol metabolic process(GO:0019348) |
1.0 | 5.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
1.0 | 2.1 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
1.0 | 4.2 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
1.0 | 3.1 | GO:0035094 | response to nicotine(GO:0035094) |
1.0 | 2.1 | GO:0014889 | muscle atrophy(GO:0014889) |
1.0 | 10.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
1.0 | 2.1 | GO:0072203 | cell proliferation involved in metanephros development(GO:0072203) |
1.0 | 7.2 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
1.0 | 3.1 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
1.0 | 2.0 | GO:0015824 | proline transport(GO:0015824) |
1.0 | 2.0 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
1.0 | 3.0 | GO:0019042 | viral latency(GO:0019042) |
1.0 | 4.1 | GO:0016266 | O-glycan processing(GO:0016266) |
1.0 | 2.0 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
1.0 | 16.1 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
1.0 | 2.0 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
1.0 | 39.5 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
1.0 | 11.8 | GO:0097352 | autophagosome maturation(GO:0097352) |
1.0 | 5.9 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
1.0 | 2.0 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
1.0 | 2.9 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
1.0 | 1.0 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
1.0 | 8.8 | GO:0099531 | presynaptic process involved in chemical synaptic transmission(GO:0099531) |
1.0 | 12.7 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
1.0 | 2.9 | GO:0002159 | desmosome assembly(GO:0002159) |
1.0 | 1.0 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
1.0 | 19.4 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
1.0 | 19.4 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
1.0 | 9.7 | GO:0060043 | regulation of cardiac muscle cell proliferation(GO:0060043) |
1.0 | 4.8 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
1.0 | 4.8 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
1.0 | 1.0 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
1.0 | 3.8 | GO:0018343 | protein farnesylation(GO:0018343) |
1.0 | 11.5 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
1.0 | 13.4 | GO:0097186 | amelogenesis(GO:0097186) |
1.0 | 5.7 | GO:0097264 | self proteolysis(GO:0097264) |
1.0 | 9.5 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
1.0 | 1.0 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
1.0 | 3.8 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.9 | 10.4 | GO:0030901 | midbrain development(GO:0030901) |
0.9 | 0.9 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.9 | 0.9 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.9 | 8.5 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.9 | 1.9 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.9 | 2.8 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.9 | 3.7 | GO:0042756 | drinking behavior(GO:0042756) |
0.9 | 0.9 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.9 | 2.8 | GO:0001842 | neural fold formation(GO:0001842) |
0.9 | 1.9 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.9 | 1.9 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.9 | 1.9 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.9 | 1.8 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.9 | 1.8 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.9 | 6.4 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.9 | 4.6 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.9 | 0.9 | GO:1900271 | regulation of long-term synaptic potentiation(GO:1900271) |
0.9 | 3.6 | GO:0036035 | osteoclast development(GO:0036035) |
0.9 | 2.7 | GO:0015816 | glycine transport(GO:0015816) |
0.9 | 7.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.9 | 5.4 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.9 | 2.7 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.9 | 19.7 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.9 | 4.5 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.9 | 2.7 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.9 | 3.6 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.9 | 6.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.9 | 8.0 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.9 | 2.7 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.9 | 0.9 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.9 | 10.6 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.9 | 8.8 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) |
0.9 | 2.6 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.9 | 2.6 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.9 | 8.8 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.9 | 1.7 | GO:0030576 | Cajal body organization(GO:0030576) |
0.9 | 4.4 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.9 | 2.6 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.9 | 4.4 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.9 | 1.7 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.9 | 1.7 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.9 | 2.6 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.9 | 4.3 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.9 | 0.9 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.9 | 3.4 | GO:0003203 | endocardial cushion morphogenesis(GO:0003203) |
0.9 | 3.4 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.9 | 2.6 | GO:0015888 | thiamine transport(GO:0015888) |
0.9 | 1.7 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.8 | 4.2 | GO:0042737 | drug catabolic process(GO:0042737) |
0.8 | 4.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.8 | 8.4 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.8 | 5.9 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.8 | 12.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.8 | 0.8 | GO:0035973 | aggrephagy(GO:0035973) |
0.8 | 0.8 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.8 | 1.7 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.8 | 3.3 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.8 | 1.7 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.8 | 3.3 | GO:0048478 | replication fork protection(GO:0048478) |
0.8 | 2.5 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.8 | 6.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.8 | 3.3 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.8 | 0.8 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.8 | 0.8 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.8 | 12.3 | GO:0042246 | tissue regeneration(GO:0042246) |
0.8 | 1.6 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.8 | 1.6 | GO:0021885 | forebrain cell migration(GO:0021885) |
0.8 | 2.5 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.8 | 0.8 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.8 | 9.8 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.8 | 7.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.8 | 2.5 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.8 | 1.6 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.8 | 3.3 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.8 | 2.4 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.8 | 1.6 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.8 | 0.8 | GO:1904478 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
0.8 | 3.2 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.8 | 1.6 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.8 | 7.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.8 | 1.6 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.8 | 1.6 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.8 | 3.2 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.8 | 3.2 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.8 | 7.1 | GO:0021772 | olfactory bulb development(GO:0021772) |
0.8 | 4.7 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.8 | 6.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.8 | 3.9 | GO:0009115 | purine nucleobase catabolic process(GO:0006145) xanthine catabolic process(GO:0009115) |
0.8 | 4.7 | GO:0021795 | cerebral cortex cell migration(GO:0021795) |
0.8 | 1.6 | GO:0070268 | cornification(GO:0070268) |
0.8 | 0.8 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.8 | 2.3 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.8 | 3.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.8 | 3.0 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.8 | 3.8 | GO:0042436 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.8 | 2.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.8 | 1.5 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.8 | 3.0 | GO:0018377 | protein myristoylation(GO:0018377) |
0.7 | 0.7 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.7 | 2.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.7 | 1.5 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.7 | 2.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.7 | 3.0 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.7 | 1.5 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.7 | 5.2 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.7 | 4.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.7 | 2.2 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.7 | 34.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.7 | 1.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.7 | 9.5 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.7 | 8.0 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.7 | 4.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.7 | 3.6 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.7 | 1.4 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.7 | 0.7 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.7 | 0.7 | GO:0070432 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
0.7 | 7.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.7 | 6.4 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.7 | 4.2 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.7 | 3.5 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.7 | 1.4 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.7 | 0.7 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.7 | 6.9 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.7 | 3.4 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.7 | 1.4 | GO:0019086 | late viral transcription(GO:0019086) |
0.7 | 1.4 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.7 | 1.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.7 | 2.0 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.7 | 2.7 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.7 | 0.7 | GO:0008228 | opsonization(GO:0008228) |
0.7 | 1.4 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.7 | 4.0 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.7 | 1.3 | GO:0072606 | interleukin-8 secretion(GO:0072606) positive regulation of interleukin-8 secretion(GO:2000484) |
0.7 | 37.7 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.7 | 10.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.7 | 9.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.7 | 0.7 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.7 | 1.3 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.7 | 2.7 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
0.7 | 1.3 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.7 | 0.7 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.7 | 3.9 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.7 | 0.7 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.7 | 0.7 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.6 | 1.9 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.6 | 2.6 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.6 | 1.9 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.6 | 1.3 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.6 | 1.9 | GO:0021554 | optic nerve development(GO:0021554) |
0.6 | 0.6 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.6 | 3.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.6 | 2.6 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.6 | 1.9 | GO:0035878 | nail development(GO:0035878) |
0.6 | 1.3 | GO:1903792 | negative regulation of anion transport(GO:1903792) |
0.6 | 0.6 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.6 | 1.9 | GO:0046618 | drug export(GO:0046618) |
0.6 | 0.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.6 | 2.5 | GO:0006415 | translational termination(GO:0006415) |
0.6 | 2.5 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.6 | 0.6 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.6 | 5.0 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.6 | 1.9 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.6 | 1.9 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.6 | 4.9 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.6 | 1.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.6 | 1.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.6 | 1.8 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.6 | 4.3 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.6 | 1.2 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.6 | 2.4 | GO:0015886 | heme transport(GO:0015886) |
0.6 | 9.0 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.6 | 1.8 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.6 | 0.6 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.6 | 0.6 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.6 | 1.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.6 | 1.2 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.6 | 2.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.6 | 0.6 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.6 | 14.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.6 | 1.2 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.6 | 0.6 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.6 | 1.7 | GO:0002254 | kinin cascade(GO:0002254) |
0.6 | 1.7 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.6 | 1.7 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.6 | 4.0 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.6 | 0.6 | GO:0032376 | positive regulation of cholesterol efflux(GO:0010875) positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.6 | 6.2 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.6 | 13.0 | GO:0015914 | phospholipid transport(GO:0015914) |
0.6 | 3.4 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.6 | 0.6 | GO:0048664 | neuron fate determination(GO:0048664) |
0.6 | 2.8 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.6 | 3.9 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.6 | 1.7 | GO:0032060 | bleb assembly(GO:0032060) |
0.6 | 3.3 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.6 | 1.1 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.6 | 3.3 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.6 | 2.8 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.6 | 0.6 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.5 | 7.1 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.5 | 1.6 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.5 | 0.5 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.5 | 1.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.5 | 1.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.5 | 22.8 | GO:0000910 | cytokinesis(GO:0000910) |
0.5 | 7.6 | GO:0044804 | nucleophagy(GO:0044804) |
0.5 | 2.2 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.5 | 1.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.5 | 1.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.5 | 1.1 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.5 | 1.1 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.5 | 1.6 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.5 | 1.1 | GO:2001053 | regulation of mesenchymal cell apoptotic process(GO:2001053) |
0.5 | 2.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.5 | 0.5 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.5 | 1.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.5 | 6.8 | GO:0017144 | drug metabolic process(GO:0017144) |
0.5 | 2.6 | GO:0007588 | excretion(GO:0007588) |
0.5 | 2.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.5 | 1.0 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.5 | 1.0 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.5 | 1.0 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.5 | 1.5 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.5 | 12.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.5 | 2.6 | GO:0030804 | positive regulation of cyclic nucleotide biosynthetic process(GO:0030804) |
0.5 | 7.2 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.5 | 12.7 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.5 | 2.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.5 | 1.5 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.5 | 0.5 | GO:0003383 | apical constriction(GO:0003383) |
0.5 | 0.5 | GO:0071637 | monocyte chemotactic protein-1 production(GO:0071605) regulation of monocyte chemotactic protein-1 production(GO:0071637) |
0.5 | 0.5 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.5 | 0.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.5 | 1.0 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.5 | 0.5 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.5 | 1.5 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.5 | 1.5 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.5 | 1.0 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.5 | 0.5 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.5 | 1.9 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.5 | 1.9 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.5 | 1.4 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.5 | 7.2 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.5 | 0.5 | GO:0070169 | positive regulation of biomineral tissue development(GO:0070169) |
0.5 | 5.7 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.5 | 3.3 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.5 | 1.4 | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.5 | 1.9 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.5 | 0.5 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.5 | 0.5 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.5 | 1.4 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.5 | 0.5 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.5 | 0.9 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.5 | 1.4 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.5 | 0.9 | GO:0045141 | meiotic telomere clustering(GO:0045141) |
0.5 | 2.8 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.5 | 6.0 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.5 | 6.0 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.5 | 0.5 | GO:0016137 | glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) |
0.5 | 3.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.5 | 3.7 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.5 | 4.6 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.5 | 0.9 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.5 | 2.7 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.5 | 6.8 | GO:0007032 | endosome organization(GO:0007032) |
0.4 | 1.3 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.4 | 2.7 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.4 | 0.4 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.4 | 1.8 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.4 | 0.4 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.4 | 0.4 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.4 | 0.4 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.4 | 0.4 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.4 | 0.9 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.4 | 0.9 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.4 | 0.9 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.4 | 0.4 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.4 | 0.9 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.4 | 0.4 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.4 | 0.4 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.4 | 0.4 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.4 | 1.8 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.4 | 0.9 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.4 | 0.4 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.4 | 0.9 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.4 | 0.4 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.4 | 0.4 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.4 | 1.7 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.4 | 1.7 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.4 | 0.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.4 | 0.4 | GO:0060166 | olfactory pit development(GO:0060166) |
0.4 | 1.3 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.4 | 0.4 | GO:0014033 | neural crest cell differentiation(GO:0014033) |
0.4 | 1.3 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.4 | 0.8 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.4 | 0.8 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.4 | 2.9 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.4 | 0.8 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.4 | 0.8 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.4 | 0.8 | GO:0051383 | kinetochore organization(GO:0051383) |
0.4 | 1.3 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.4 | 0.4 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.4 | 0.4 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.4 | 0.8 | GO:0030578 | PML body organization(GO:0030578) |
0.4 | 0.8 | GO:0048668 | collateral sprouting(GO:0048668) |
0.4 | 0.4 | GO:0070305 | response to cGMP(GO:0070305) |
0.4 | 2.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.4 | 24.8 | GO:0007601 | visual perception(GO:0007601) |
0.4 | 2.8 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.4 | 1.2 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.4 | 1.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.4 | 0.4 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.4 | 2.4 | GO:0055062 | phosphate ion homeostasis(GO:0055062) cellular divalent inorganic anion homeostasis(GO:0072501) trivalent inorganic anion homeostasis(GO:0072506) |
0.4 | 1.2 | GO:0007343 | egg activation(GO:0007343) |
0.4 | 0.8 | GO:0042476 | odontogenesis(GO:0042476) |
0.4 | 0.8 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.4 | 1.6 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.4 | 2.0 | GO:0015074 | DNA integration(GO:0015074) |
0.4 | 0.4 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.4 | 1.6 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.4 | 3.6 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.4 | 0.8 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.4 | 3.5 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.4 | 75.9 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.4 | 0.8 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.4 | 4.3 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.4 | 3.5 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.4 | 3.9 | GO:0043574 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.4 | 1.9 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.4 | 4.7 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
0.4 | 35.5 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.4 | 1.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.4 | 3.8 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.4 | 1.5 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.4 | 3.0 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.4 | 0.8 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.4 | 0.4 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.4 | 1.1 | GO:0050685 | positive regulation of mRNA processing(GO:0050685) |
0.4 | 1.1 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.4 | 1.9 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.4 | 2.6 | GO:0050892 | intestinal absorption(GO:0050892) |
0.4 | 1.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 1.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.4 | 0.7 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.4 | 7.3 | GO:0007631 | feeding behavior(GO:0007631) |
0.4 | 1.1 | GO:0051896 | regulation of protein kinase B signaling(GO:0051896) |
0.4 | 1.8 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.4 | 0.4 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.4 | 0.4 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.4 | 0.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.4 | 2.2 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.4 | 4.7 | GO:0090307 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.4 | 1.4 | GO:0044110 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.4 | 0.4 | GO:0030421 | defecation(GO:0030421) |
0.4 | 5.3 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.4 | 2.8 | GO:0051180 | vitamin transport(GO:0051180) |
0.4 | 2.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.4 | 0.4 | GO:0008306 | associative learning(GO:0008306) |
0.4 | 0.4 | GO:0009414 | response to water deprivation(GO:0009414) |
0.3 | 1.4 | GO:0051279 | regulation of release of sequestered calcium ion into cytosol(GO:0051279) |
0.3 | 3.8 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.3 | 0.3 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.3 | 12.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.3 | 0.3 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.3 | 1.4 | GO:0001662 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) |
0.3 | 3.4 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.3 | 0.7 | GO:0050922 | negative regulation of leukocyte chemotaxis(GO:0002689) negative regulation of chemotaxis(GO:0050922) |
0.3 | 1.0 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.3 | 1.3 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.3 | 1.7 | GO:1903556 | negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.3 | 0.7 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.3 | 0.7 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.3 | 0.3 | GO:0010226 | response to lithium ion(GO:0010226) |
0.3 | 1.3 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.3 | 0.3 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.3 | 1.0 | GO:0018101 | protein citrullination(GO:0018101) |
0.3 | 1.6 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 0.3 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.3 | 0.6 | GO:2000318 | regulation of T-helper 17 type immune response(GO:2000316) positive regulation of T-helper 17 type immune response(GO:2000318) |
0.3 | 0.3 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.3 | 0.3 | GO:0060430 | lung saccule development(GO:0060430) |
0.3 | 1.6 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.3 | 0.3 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.3 | 0.3 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.3 | 0.3 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.3 | 0.6 | GO:0007187 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger(GO:0007187) |
0.3 | 1.9 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.3 | 0.6 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.3 | 0.3 | GO:0060539 | diaphragm development(GO:0060539) |
0.3 | 0.9 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.3 | 0.3 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.3 | 1.8 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
0.3 | 1.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.3 | 0.6 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.3 | 0.3 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.3 | 0.6 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.3 | 0.3 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.3 | 1.2 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.3 | 0.3 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.3 | 2.1 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.3 | 1.2 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.3 | 1.5 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.3 | 0.3 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.3 | 0.6 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.3 | 0.3 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.3 | 5.2 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.3 | 0.3 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.3 | 0.9 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.3 | 0.9 | GO:0051181 | cofactor transport(GO:0051181) |
0.3 | 0.6 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.3 | 0.3 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.3 | 6.7 | GO:0050709 | negative regulation of protein secretion(GO:0050709) |
0.3 | 6.2 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.3 | 1.4 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.3 | 1.1 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.3 | 0.8 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.3 | 0.8 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.3 | 0.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 1.1 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.3 | 0.5 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.3 | 0.3 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.3 | 3.5 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.3 | 0.3 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.3 | 1.1 | GO:0051031 | tRNA transport(GO:0051031) |
0.3 | 0.5 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.3 | 2.1 | GO:0031294 | lymphocyte costimulation(GO:0031294) |
0.3 | 2.6 | GO:0001756 | somitogenesis(GO:0001756) |
0.3 | 0.3 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.3 | 5.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.3 | 1.8 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.3 | 1.0 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.3 | 1.5 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.3 | 0.5 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.3 | 0.8 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.3 | 6.3 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.2 | 0.5 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 0.2 | GO:0014866 | skeletal myofibril assembly(GO:0014866) skeletal muscle thin filament assembly(GO:0030240) |
0.2 | 0.7 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.2 | 2.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.2 | 0.7 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) |
0.2 | 0.2 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
0.2 | 0.5 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.2 | 0.7 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.2 | 0.5 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.2 | 0.5 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.2 | 0.5 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 1.6 | GO:0097435 | fibril organization(GO:0097435) |
0.2 | 0.2 | GO:0043200 | response to amino acid(GO:0043200) |
0.2 | 0.2 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.2 | 0.7 | GO:0006901 | vesicle coating(GO:0006901) |
0.2 | 2.2 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.2 | 0.2 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.2 | 0.4 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.2 | 1.1 | GO:0009208 | pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) |
0.2 | 22.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.2 | 0.4 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.2 | 1.5 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.2 | 1.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.2 | 0.2 | GO:2001179 | regulation of interleukin-10 secretion(GO:2001179) |
0.2 | 0.2 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.2 | 0.8 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.6 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.2 | 0.2 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.2 | 1.4 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.2 | 0.4 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.2 | 1.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 0.2 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.2 | 0.2 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.2 | 0.4 | GO:0072567 | chemokine (C-X-C motif) ligand 2 production(GO:0072567) regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
0.2 | 0.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.2 | 0.4 | GO:0002076 | osteoblast development(GO:0002076) |
0.2 | 1.0 | GO:0033273 | response to vitamin(GO:0033273) |
0.2 | 0.4 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.2 | 0.4 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.2 | 0.4 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.2 | 0.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.2 | 2.6 | GO:0048286 | lung alveolus development(GO:0048286) |
0.2 | 0.2 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 0.2 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 2.5 | GO:0050804 | modulation of synaptic transmission(GO:0050804) |
0.2 | 2.7 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.2 | 0.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.2 | 0.4 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.2 | 0.2 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.2 | 1.3 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 0.4 | GO:0070723 | response to cholesterol(GO:0070723) |
0.2 | 0.2 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.2 | 0.4 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.2 | 1.3 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 0.2 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.2 | 0.6 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.2 | 0.4 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 0.4 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.2 | 7.3 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.2 | 195.2 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.2 | 2.0 | GO:0048536 | spleen development(GO:0048536) |
0.2 | 2.3 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.2 | 0.7 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.2 | 0.2 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.2 | 0.9 | GO:0006903 | vesicle targeting(GO:0006903) |
0.2 | 0.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 1.1 | GO:0007135 | meiosis II(GO:0007135) |
0.2 | 0.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 0.3 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.2 | 0.2 | GO:0002739 | regulation of cytokine secretion involved in immune response(GO:0002739) |
0.2 | 0.2 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.2 | 1.5 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.2 | 0.5 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.2 | 0.7 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 0.8 | GO:0021517 | ventral spinal cord development(GO:0021517) |
0.2 | 0.5 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 1.0 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 0.2 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.2 | 10.7 | GO:0071219 | cellular response to molecule of bacterial origin(GO:0071219) |
0.2 | 0.5 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.2 | 0.3 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 4.9 | GO:0050890 | cognition(GO:0050890) |
0.2 | 1.7 | GO:0045471 | response to ethanol(GO:0045471) |
0.2 | 0.9 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.2 | 0.9 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.2 | 0.2 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.2 | 0.2 | GO:0001805 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.1 | 0.3 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.6 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.1 | 0.1 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.1 | 0.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 1.4 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 4.5 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.1 | 1.0 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.1 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) |
0.1 | 0.1 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.1 | 0.4 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.6 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.1 | GO:0072044 | collecting duct development(GO:0072044) |
0.1 | 0.8 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.1 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.1 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.3 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.1 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 2.3 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.1 | 0.5 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.1 | 0.1 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.8 | GO:0032634 | interleukin-5 production(GO:0032634) |
0.1 | 0.3 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.3 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 1.0 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.3 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.1 | 0.4 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.2 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.1 | 0.2 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 3.7 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 0.5 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.5 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.7 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.2 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.1 | 0.7 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
0.1 | 1.1 | GO:0006323 | DNA packaging(GO:0006323) |
0.1 | 0.6 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.1 | 0.1 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.1 | 0.1 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.3 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.1 | GO:0010524 | positive regulation of calcium ion transport into cytosol(GO:0010524) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 2.4 | GO:0042089 | cytokine biosynthetic process(GO:0042089) |
0.1 | 0.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.3 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.4 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.1 | 0.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.2 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 0.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.2 | GO:0070266 | necroptotic process(GO:0070266) |
0.1 | 0.1 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.1 | 7.1 | GO:0048515 | spermatid differentiation(GO:0048515) |
0.1 | 0.6 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.1 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 0.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.2 | GO:0001832 | blastocyst growth(GO:0001832) |
0.1 | 0.3 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
0.1 | 0.2 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.1 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.1 | 0.2 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 0.1 | GO:0043243 | positive regulation of protein complex disassembly(GO:0043243) |
0.1 | 0.5 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.1 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.1 | 0.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.1 | 0.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.1 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.1 | 0.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.1 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.1 | 0.3 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 0.3 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 1.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.4 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.1 | 0.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.1 | 0.2 | GO:0038094 | Fc receptor signaling pathway(GO:0038093) Fc-gamma receptor signaling pathway(GO:0038094) |
0.1 | 0.1 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.1 | 0.7 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.2 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.1 | 0.1 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.1 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 0.1 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.1 | 0.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.1 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.1 | 0.1 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.1 | 0.5 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.1 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.1 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.1 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.1 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.1 | 0.3 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.2 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.1 | 0.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.1 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.1 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.1 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.1 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.2 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.1 | 0.1 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.1 | 0.4 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 0.1 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 0.2 | GO:0097459 | iron ion import into cell(GO:0097459) |
0.1 | 0.2 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.1 | 0.3 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.1 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.3 | GO:0001709 | cell fate determination(GO:0001709) |
0.1 | 0.4 | GO:0035303 | regulation of dephosphorylation(GO:0035303) |
0.1 | 0.1 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.0 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.0 | 0.0 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.0 | 0.1 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.0 | 0.0 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.0 | 0.1 | GO:0042516 | regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
0.0 | 0.0 | GO:0050773 | regulation of dendrite development(GO:0050773) |
0.0 | 1.3 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.0 | 0.0 | GO:1901317 | regulation of sperm motility(GO:1901317) positive regulation of sperm motility(GO:1902093) |
0.0 | 0.1 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.0 | 0.2 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.0 | 0.0 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.0 | 0.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.0 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.0 | 0.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.0 | 0.0 | GO:1905153 | regulation of membrane invagination(GO:1905153) |
0.0 | 0.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.1 | GO:0060416 | response to growth hormone(GO:0060416) |
0.0 | 0.1 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 0.0 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 1.2 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.1 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.0 | 0.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.1 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.0 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.0 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.0 | 0.1 | GO:0019740 | nitrogen utilization(GO:0019740) |
0.0 | 0.0 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.0 | 0.0 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.1 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.0 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.1 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.0 | 0.0 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.0 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.0 | 0.1 | GO:0015819 | lysine transport(GO:0015819) |
0.0 | 0.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.0 | GO:0018214 | protein carboxylation(GO:0018214) |
0.0 | 0.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.0 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.0 | 0.0 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.0 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 | 0.0 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.0 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.0 | 0.0 | GO:0070341 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
0.0 | 0.0 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.0 | 0.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.0 | 0.0 | GO:0051349 | positive regulation of lyase activity(GO:0051349) |
0.0 | 0.0 | GO:0098764 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.0 | 0.0 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.0 | 0.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.0 | GO:0061245 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.0 | 0.0 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
29.7 | 89.0 | GO:1990812 | growth cone filopodium(GO:1990812) |
29.6 | 118.3 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
29.5 | 88.6 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
28.1 | 28.1 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
20.0 | 399.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
16.2 | 16.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
14.2 | 28.4 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
14.2 | 42.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
13.3 | 53.3 | GO:0044308 | axonal spine(GO:0044308) |
12.4 | 111.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
12.0 | 60.1 | GO:0005579 | membrane attack complex(GO:0005579) |
11.4 | 34.3 | GO:0044393 | microspike(GO:0044393) |
11.3 | 22.7 | GO:0008091 | spectrin(GO:0008091) |
10.8 | 64.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
10.5 | 63.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
9.5 | 37.9 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
9.3 | 92.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
8.5 | 204.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
8.4 | 159.0 | GO:0030673 | axolemma(GO:0030673) |
8.1 | 24.4 | GO:0032437 | cuticular plate(GO:0032437) |
7.8 | 31.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
7.8 | 31.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
7.7 | 61.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
7.6 | 38.1 | GO:0097433 | dense body(GO:0097433) |
7.2 | 21.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
7.1 | 56.6 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
7.1 | 42.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
6.9 | 13.8 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
6.8 | 40.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
6.4 | 70.5 | GO:0032433 | filopodium tip(GO:0032433) |
6.3 | 44.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
5.9 | 17.8 | GO:0097427 | microtubule bundle(GO:0097427) |
5.9 | 23.6 | GO:0000235 | astral microtubule(GO:0000235) |
5.8 | 17.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
5.8 | 11.6 | GO:0042827 | platelet dense granule(GO:0042827) |
5.6 | 67.5 | GO:0071565 | nBAF complex(GO:0071565) |
5.5 | 16.5 | GO:0000322 | storage vacuole(GO:0000322) |
5.4 | 43.1 | GO:0043194 | axon initial segment(GO:0043194) |
5.3 | 95.9 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
5.3 | 26.3 | GO:0045202 | synapse(GO:0045202) |
5.2 | 89.0 | GO:0001741 | XY body(GO:0001741) |
5.2 | 36.5 | GO:0071437 | invadopodium(GO:0071437) |
5.1 | 10.1 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
4.9 | 19.8 | GO:0034464 | BBSome(GO:0034464) |
4.9 | 34.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
4.8 | 43.1 | GO:0031527 | filopodium membrane(GO:0031527) |
4.8 | 19.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
4.7 | 71.0 | GO:0035371 | microtubule plus-end(GO:0035371) |
4.7 | 9.4 | GO:0033010 | paranodal junction(GO:0033010) |
4.7 | 4.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
4.7 | 14.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
4.6 | 120.1 | GO:0044295 | axonal growth cone(GO:0044295) |
4.5 | 254.3 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
4.4 | 13.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
4.3 | 30.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
4.3 | 12.9 | GO:0005955 | calcineurin complex(GO:0005955) |
4.2 | 8.5 | GO:0097441 | basilar dendrite(GO:0097441) |
4.2 | 12.5 | GO:0097451 | glial limiting end-foot(GO:0097451) |
4.2 | 58.4 | GO:0031430 | M band(GO:0031430) |
4.2 | 8.3 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
4.1 | 8.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
4.0 | 12.1 | GO:0032127 | dense core granule membrane(GO:0032127) |
4.0 | 36.0 | GO:0036156 | inner dynein arm(GO:0036156) |
3.9 | 154.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
3.7 | 333.9 | GO:0043204 | perikaryon(GO:0043204) |
3.6 | 10.9 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
3.6 | 107.3 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
3.6 | 28.6 | GO:0060091 | kinocilium(GO:0060091) |
3.6 | 14.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
3.5 | 17.7 | GO:0005883 | neurofilament(GO:0005883) |
3.5 | 10.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
3.4 | 13.6 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
3.3 | 13.2 | GO:1990130 | Iml1 complex(GO:1990130) |
3.3 | 22.8 | GO:0016342 | catenin complex(GO:0016342) |
3.2 | 19.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
3.2 | 6.3 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
3.2 | 12.6 | GO:0032585 | multivesicular body membrane(GO:0032585) |
3.1 | 9.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
3.0 | 27.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
3.0 | 20.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
3.0 | 23.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
2.9 | 20.6 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
2.8 | 11.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
2.8 | 11.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
2.8 | 8.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
2.7 | 131.4 | GO:0072686 | mitotic spindle(GO:0072686) |
2.6 | 5.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
2.6 | 5.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
2.6 | 30.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
2.5 | 22.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
2.4 | 7.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
2.4 | 39.1 | GO:0005614 | interstitial matrix(GO:0005614) |
2.4 | 4.8 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
2.4 | 9.7 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
2.4 | 7.2 | GO:0005606 | laminin-1 complex(GO:0005606) |
2.4 | 9.6 | GO:1990246 | uniplex complex(GO:1990246) |
2.4 | 9.5 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
2.4 | 2.4 | GO:0016272 | prefoldin complex(GO:0016272) |
2.4 | 7.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
2.2 | 293.6 | GO:0060076 | excitatory synapse(GO:0060076) |
2.2 | 6.6 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
2.1 | 19.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
2.1 | 8.5 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
2.1 | 6.3 | GO:0072534 | perineuronal net(GO:0072534) |
2.1 | 24.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
2.0 | 8.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
2.0 | 18.0 | GO:0005869 | dynactin complex(GO:0005869) |
2.0 | 22.0 | GO:0010369 | chromocenter(GO:0010369) |
2.0 | 2.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
1.9 | 1.9 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.9 | 7.8 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
1.9 | 29.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.9 | 5.7 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.9 | 9.3 | GO:0061617 | MICOS complex(GO:0061617) |
1.9 | 9.3 | GO:0097255 | R2TP complex(GO:0097255) |
1.8 | 7.3 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
1.8 | 12.8 | GO:0044232 | organelle membrane contact site(GO:0044232) |
1.8 | 10.7 | GO:0043198 | dendritic shaft(GO:0043198) |
1.7 | 10.5 | GO:0005871 | kinesin complex(GO:0005871) |
1.7 | 12.0 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
1.7 | 51.0 | GO:0044853 | plasma membrane raft(GO:0044853) |
1.7 | 10.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
1.7 | 6.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.6 | 13.1 | GO:0032797 | SMN complex(GO:0032797) |
1.6 | 9.8 | GO:0031415 | NatA complex(GO:0031415) |
1.6 | 4.8 | GO:0070939 | Dsl1p complex(GO:0070939) |
1.6 | 11.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.6 | 3.2 | GO:0070695 | FHF complex(GO:0070695) |
1.6 | 4.7 | GO:0071942 | XPC complex(GO:0071942) |
1.6 | 14.0 | GO:0072546 | ER membrane protein complex(GO:0072546) |
1.5 | 13.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
1.5 | 21.7 | GO:0070822 | Sin3-type complex(GO:0070822) |
1.5 | 9.3 | GO:0097342 | ripoptosome(GO:0097342) |
1.5 | 22.7 | GO:0044298 | cell body membrane(GO:0044298) |
1.5 | 3.0 | GO:0043203 | axon hillock(GO:0043203) |
1.5 | 10.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
1.5 | 4.5 | GO:0031523 | Myb complex(GO:0031523) |
1.5 | 6.0 | GO:0030891 | VCB complex(GO:0030891) |
1.5 | 4.5 | GO:0071817 | MMXD complex(GO:0071817) |
1.5 | 7.4 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
1.5 | 65.3 | GO:0016459 | myosin complex(GO:0016459) |
1.5 | 3.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.5 | 4.4 | GO:0043083 | synaptic cleft(GO:0043083) |
1.5 | 10.3 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
1.5 | 10.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
1.5 | 201.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
1.5 | 4.4 | GO:0097449 | astrocyte projection(GO:0097449) |
1.5 | 234.1 | GO:0005769 | early endosome(GO:0005769) |
1.5 | 4.4 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
1.5 | 32.1 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
1.5 | 11.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
1.4 | 39.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
1.4 | 5.6 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
1.4 | 8.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
1.4 | 25.1 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
1.3 | 14.7 | GO:0014704 | intercalated disc(GO:0014704) |
1.3 | 4.0 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
1.3 | 4.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
1.3 | 4.0 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
1.3 | 2.7 | GO:0043511 | inhibin complex(GO:0043511) |
1.3 | 29.9 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
1.3 | 1.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
1.3 | 7.8 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
1.3 | 19.0 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
1.3 | 10.1 | GO:0001520 | outer dense fiber(GO:0001520) |
1.3 | 48.1 | GO:0032432 | stress fiber(GO:0001725) actin filament bundle(GO:0032432) contractile actin filament bundle(GO:0097517) |
1.3 | 5.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.3 | 1.3 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
1.3 | 8.8 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.3 | 3.8 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
1.2 | 25.0 | GO:0001772 | immunological synapse(GO:0001772) |
1.2 | 16.1 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
1.2 | 67.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
1.2 | 9.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
1.2 | 18.4 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
1.2 | 1.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
1.2 | 3.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
1.2 | 6.0 | GO:0042629 | mast cell granule(GO:0042629) |
1.2 | 2.4 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
1.2 | 11.9 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
1.2 | 1.2 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
1.2 | 4.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
1.2 | 42.1 | GO:0045171 | intercellular bridge(GO:0045171) |
1.2 | 15.1 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
1.2 | 12.7 | GO:0001527 | microfibril(GO:0001527) |
1.1 | 5.7 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
1.1 | 308.3 | GO:0005874 | microtubule(GO:0005874) |
1.1 | 34.3 | GO:0034704 | calcium channel complex(GO:0034704) |
1.1 | 27.1 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
1.1 | 9.0 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
1.1 | 10.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
1.1 | 6.7 | GO:0071546 | pi-body(GO:0071546) |
1.1 | 10.0 | GO:0031932 | TORC2 complex(GO:0031932) |
1.1 | 39.3 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
1.1 | 81.1 | GO:0005581 | collagen trimer(GO:0005581) |
1.1 | 20.4 | GO:0035861 | site of double-strand break(GO:0035861) |
1.1 | 9.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
1.1 | 3.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.0 | 12.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
1.0 | 8.3 | GO:0042575 | DNA polymerase complex(GO:0042575) |
1.0 | 7.2 | GO:0030904 | retromer complex(GO:0030904) |
1.0 | 62.0 | GO:0010008 | endosome membrane(GO:0010008) |
1.0 | 10.3 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.0 | 8.2 | GO:0097440 | apical dendrite(GO:0097440) |
1.0 | 1.0 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
1.0 | 4.1 | GO:0002177 | manchette(GO:0002177) |
1.0 | 87.1 | GO:0001669 | acrosomal vesicle(GO:0001669) |
1.0 | 14.1 | GO:0030057 | desmosome(GO:0030057) |
1.0 | 9.0 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
1.0 | 7.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
1.0 | 3.0 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
1.0 | 5.9 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
1.0 | 1.9 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.9 | 99.9 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.9 | 203.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.9 | 2.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.9 | 11.1 | GO:1990391 | DNA repair complex(GO:1990391) |
0.9 | 2.8 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.9 | 4.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.9 | 19.9 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.9 | 18.0 | GO:0016235 | aggresome(GO:0016235) |
0.9 | 23.2 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.9 | 6.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.9 | 2.6 | GO:1990393 | 3M complex(GO:1990393) |
0.8 | 5.1 | GO:0000812 | Swr1 complex(GO:0000812) |
0.8 | 4.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.8 | 3.3 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.8 | 4.9 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.8 | 3.3 | GO:0043196 | varicosity(GO:0043196) |
0.8 | 66.6 | GO:0097060 | synaptic membrane(GO:0097060) |
0.8 | 2.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.8 | 30.7 | GO:0005884 | actin filament(GO:0005884) |
0.8 | 1.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.8 | 17.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.8 | 3.8 | GO:0031674 | I band(GO:0031674) |
0.8 | 19.1 | GO:0005921 | gap junction(GO:0005921) |
0.8 | 5.3 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.8 | 0.8 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.8 | 18.1 | GO:0043234 | protein complex(GO:0043234) |
0.8 | 9.0 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.8 | 7.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.8 | 49.5 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.7 | 2.2 | GO:0031417 | NatC complex(GO:0031417) |
0.7 | 1.5 | GO:0097413 | Lewy body(GO:0097413) |
0.7 | 3.7 | GO:0000796 | condensin complex(GO:0000796) |
0.7 | 28.9 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.7 | 2.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.7 | 2.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.7 | 620.8 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.7 | 1.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.7 | 4.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.7 | 1.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.7 | 2.0 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.7 | 29.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.7 | 23.5 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.7 | 2.0 | GO:0043293 | apoptosome(GO:0043293) |
0.7 | 2.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.7 | 4.0 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.7 | 3.3 | GO:0034709 | methylosome(GO:0034709) |
0.6 | 38.7 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.6 | 2.6 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.6 | 0.6 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.6 | 1.3 | GO:0034703 | cation channel complex(GO:0034703) |
0.6 | 0.6 | GO:0035838 | growing cell tip(GO:0035838) |
0.6 | 2.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.6 | 1.9 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.6 | 22.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.6 | 24.3 | GO:0031514 | motile cilium(GO:0031514) |
0.6 | 3.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.6 | 4.8 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
0.6 | 20.7 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.6 | 1.2 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.6 | 6.4 | GO:0097228 | sperm principal piece(GO:0097228) |
0.6 | 17.1 | GO:0030018 | Z disc(GO:0030018) |
0.6 | 4.0 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.6 | 23.0 | GO:0016605 | PML body(GO:0016605) |
0.6 | 0.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.6 | 45.1 | GO:0016607 | nuclear speck(GO:0016607) |
0.5 | 2.7 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.5 | 3.8 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.5 | 1.1 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.5 | 3.8 | GO:0031672 | A band(GO:0031672) |
0.5 | 2.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.5 | 1.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.5 | 1.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.5 | 12.5 | GO:0005844 | polysome(GO:0005844) |
0.5 | 3.1 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.5 | 2.0 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.5 | 1.5 | GO:0005745 | m-AAA complex(GO:0005745) |
0.5 | 16.4 | GO:0016592 | mediator complex(GO:0016592) |
0.5 | 1.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.5 | 0.5 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.5 | 1.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.5 | 1.9 | GO:0031045 | dense core granule(GO:0031045) |
0.5 | 3.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.5 | 1.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.5 | 7.8 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.4 | 22.7 | GO:0030684 | preribosome(GO:0030684) |
0.4 | 2.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.4 | 6.6 | GO:0030016 | myofibril(GO:0030016) |
0.4 | 2.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.4 | 1.3 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.4 | 0.9 | GO:0090543 | Flemming body(GO:0090543) |
0.4 | 3.5 | GO:0032039 | integrator complex(GO:0032039) |
0.4 | 0.9 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.4 | 0.8 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.4 | 335.2 | GO:0005576 | extracellular region(GO:0005576) |
0.4 | 3.3 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.4 | 16.6 | GO:0005811 | lipid particle(GO:0005811) |
0.4 | 1.6 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.4 | 1.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.4 | 1.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.4 | 1394.0 | GO:0016021 | integral component of membrane(GO:0016021) |
0.4 | 15.1 | GO:0031012 | extracellular matrix(GO:0031012) |
0.4 | 0.4 | GO:1990357 | terminal web(GO:1990357) |
0.4 | 2.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.3 | 2.3 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.3 | 2.6 | GO:0031201 | SNARE complex(GO:0031201) |
0.3 | 1.9 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 2.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.3 | 2.8 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.3 | 0.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.3 | 2.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.3 | 2.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.3 | 13.3 | GO:0001533 | cornified envelope(GO:0001533) |
0.3 | 28.9 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.3 | 5.1 | GO:0030426 | growth cone(GO:0030426) |
0.3 | 2.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.3 | 0.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.3 | 2.6 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.3 | 25.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.3 | 1.0 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 0.5 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 0.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.2 | 2.7 | GO:0070469 | respiratory chain(GO:0070469) |
0.2 | 2.4 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.2 | 1.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 0.5 | GO:0030427 | site of polarized growth(GO:0030427) |
0.2 | 3.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 0.2 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 0.2 | GO:0097386 | glial cell projection(GO:0097386) |
0.2 | 0.7 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 0.2 | GO:0070160 | occluding junction(GO:0070160) |
0.2 | 1.9 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 1.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 0.6 | GO:0001652 | granular component(GO:0001652) |
0.2 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 1.4 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.2 | 1.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 5.3 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.2 | 14.2 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 4.2 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.2 | 0.3 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.2 | 1045.5 | GO:0044464 | cell part(GO:0044464) |
0.1 | 0.6 | GO:0005623 | cell(GO:0005623) |
0.1 | 4.6 | GO:0016020 | membrane(GO:0016020) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
52.5 | 157.6 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
31.5 | 157.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
31.4 | 125.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
24.8 | 99.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
23.5 | 70.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
22.1 | 132.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
16.7 | 50.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
14.7 | 102.6 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
13.6 | 244.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
13.3 | 53.3 | GO:0015265 | urea channel activity(GO:0015265) |
11.8 | 59.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
11.8 | 165.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
11.4 | 34.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
11.0 | 33.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
10.9 | 32.8 | GO:0048030 | disaccharide binding(GO:0048030) |
9.8 | 39.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
9.3 | 27.9 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
9.2 | 55.0 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
9.1 | 109.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
8.7 | 43.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
8.6 | 51.7 | GO:0002054 | nucleobase binding(GO:0002054) |
8.4 | 33.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
8.3 | 74.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
8.2 | 32.9 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
8.0 | 127.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
8.0 | 87.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
7.9 | 23.6 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
7.8 | 31.2 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
7.6 | 160.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
7.2 | 7.2 | GO:0051723 | protein methylesterase activity(GO:0051723) |
7.1 | 7.1 | GO:0030487 | inositol-4,5-bisphosphate 5-phosphatase activity(GO:0030487) |
7.1 | 35.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
6.5 | 19.5 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
6.4 | 51.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
6.4 | 205.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
6.4 | 82.9 | GO:0045295 | gamma-catenin binding(GO:0045295) |
6.1 | 18.4 | GO:0052622 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
6.1 | 30.6 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
6.0 | 18.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
6.0 | 66.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
5.9 | 29.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
5.9 | 64.6 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
5.8 | 52.6 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
5.8 | 17.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
5.7 | 22.7 | GO:0038064 | collagen receptor activity(GO:0038064) |
5.6 | 67.6 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
5.6 | 11.2 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
5.5 | 5.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
5.5 | 49.7 | GO:0005522 | profilin binding(GO:0005522) |
5.5 | 21.9 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
5.4 | 26.9 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
5.2 | 21.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
5.2 | 62.5 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
5.0 | 30.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
5.0 | 69.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
4.9 | 14.6 | GO:0070699 | type II activin receptor binding(GO:0070699) |
4.8 | 9.7 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
4.7 | 9.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
4.6 | 13.9 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
4.6 | 312.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
4.6 | 128.0 | GO:0030507 | spectrin binding(GO:0030507) |
4.5 | 13.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
4.5 | 22.4 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
4.4 | 17.7 | GO:0043829 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
4.4 | 35.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
4.3 | 38.9 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
4.3 | 94.9 | GO:0045296 | cadherin binding(GO:0045296) |
4.3 | 21.3 | GO:0048495 | Roundabout binding(GO:0048495) |
4.2 | 12.7 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
4.2 | 20.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
4.1 | 61.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
4.0 | 104.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
4.0 | 16.0 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
4.0 | 39.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
4.0 | 7.9 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
4.0 | 27.7 | GO:0034802 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
4.0 | 11.9 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
4.0 | 71.2 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
3.9 | 11.7 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
3.8 | 114.6 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
3.8 | 7.6 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
3.8 | 15.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
3.8 | 22.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
3.7 | 18.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
3.7 | 22.2 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
3.6 | 7.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
3.6 | 14.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
3.6 | 7.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
3.5 | 10.6 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
3.5 | 17.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
3.5 | 17.4 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
3.5 | 24.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
3.4 | 26.9 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
3.3 | 6.7 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
3.3 | 13.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
3.3 | 19.8 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
3.2 | 9.7 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
3.2 | 6.4 | GO:0036033 | mediator complex binding(GO:0036033) |
3.2 | 28.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
3.2 | 9.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
3.1 | 22.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
3.1 | 18.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
3.1 | 84.6 | GO:0050699 | WW domain binding(GO:0050699) |
3.1 | 6.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
3.1 | 55.8 | GO:0003785 | actin monomer binding(GO:0003785) |
3.1 | 12.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
3.0 | 12.1 | GO:0045340 | mercury ion binding(GO:0045340) |
3.0 | 15.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
3.0 | 48.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
3.0 | 6.0 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
3.0 | 50.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
3.0 | 38.8 | GO:0048018 | receptor agonist activity(GO:0048018) |
3.0 | 8.9 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
2.9 | 5.9 | GO:0046030 | inositol trisphosphate phosphatase activity(GO:0046030) |
2.9 | 32.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
2.9 | 5.8 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
2.9 | 43.7 | GO:0032183 | SUMO binding(GO:0032183) |
2.9 | 119.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
2.9 | 8.7 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
2.9 | 5.7 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
2.9 | 62.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
2.9 | 8.6 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
2.9 | 11.4 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
2.9 | 77.0 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
2.8 | 8.5 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
2.8 | 11.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
2.8 | 16.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
2.7 | 8.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
2.7 | 75.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
2.7 | 8.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
2.7 | 2.7 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
2.7 | 8.1 | GO:0030553 | cGMP binding(GO:0030553) |
2.7 | 96.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
2.7 | 8.0 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
2.7 | 10.6 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
2.7 | 61.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
2.6 | 36.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
2.6 | 10.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
2.6 | 10.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
2.6 | 10.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
2.5 | 7.6 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
2.5 | 5.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
2.5 | 7.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
2.5 | 5.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
2.5 | 7.4 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
2.5 | 14.8 | GO:0035473 | lipase binding(GO:0035473) |
2.5 | 27.0 | GO:0001222 | transcription corepressor binding(GO:0001222) |
2.5 | 24.5 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
2.4 | 17.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
2.4 | 21.9 | GO:0004017 | adenylate kinase activity(GO:0004017) |
2.4 | 14.5 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
2.4 | 14.4 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
2.4 | 7.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
2.4 | 23.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
2.4 | 32.9 | GO:0030275 | LRR domain binding(GO:0030275) |
2.3 | 30.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
2.3 | 7.0 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
2.3 | 4.7 | GO:0050815 | phosphoserine binding(GO:0050815) |
2.3 | 2.3 | GO:0070411 | I-SMAD binding(GO:0070411) |
2.3 | 6.9 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
2.3 | 20.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
2.3 | 4.5 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
2.2 | 11.2 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
2.2 | 95.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
2.2 | 8.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
2.2 | 28.7 | GO:0004407 | histone deacetylase activity(GO:0004407) |
2.2 | 8.8 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
2.2 | 6.5 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
2.2 | 8.7 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
2.2 | 6.5 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
2.1 | 10.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
2.1 | 6.4 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
2.1 | 2.1 | GO:0019198 | transmembrane receptor protein phosphatase activity(GO:0019198) |
2.1 | 10.6 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
2.1 | 2.1 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
2.0 | 34.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
2.0 | 12.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
2.0 | 24.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
2.0 | 6.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
2.0 | 8.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
2.0 | 6.0 | GO:0001221 | transcription cofactor binding(GO:0001221) |
2.0 | 10.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
2.0 | 9.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
2.0 | 90.7 | GO:0017022 | myosin binding(GO:0017022) |
2.0 | 7.9 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
1.9 | 7.8 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.9 | 7.8 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
1.9 | 172.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
1.9 | 1.9 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
1.9 | 5.8 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.9 | 28.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
1.9 | 40.3 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
1.9 | 5.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.9 | 9.5 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
1.9 | 9.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.9 | 20.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
1.9 | 26.2 | GO:0052714 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
1.9 | 9.3 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
1.9 | 7.4 | GO:0016936 | galactoside binding(GO:0016936) |
1.9 | 11.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
1.8 | 7.4 | GO:0097001 | ceramide binding(GO:0097001) |
1.8 | 5.5 | GO:0016015 | morphogen activity(GO:0016015) |
1.8 | 9.2 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
1.8 | 40.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
1.8 | 11.0 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
1.8 | 10.9 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
1.8 | 21.9 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
1.8 | 45.6 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
1.8 | 9.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
1.8 | 5.5 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
1.8 | 7.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.8 | 7.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.8 | 8.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
1.8 | 7.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.8 | 14.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.7 | 7.0 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
1.7 | 7.0 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
1.7 | 17.4 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
1.7 | 3.5 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
1.7 | 5.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
1.7 | 17.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
1.7 | 1.7 | GO:0015925 | galactosidase activity(GO:0015925) |
1.7 | 40.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.7 | 1.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
1.7 | 3.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.7 | 11.6 | GO:0033691 | sialic acid binding(GO:0033691) |
1.6 | 1.6 | GO:0030492 | hemoglobin binding(GO:0030492) |
1.6 | 8.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.6 | 6.5 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
1.6 | 13.0 | GO:0004697 | protein kinase C activity(GO:0004697) |
1.6 | 4.9 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
1.6 | 6.4 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
1.6 | 4.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
1.6 | 4.7 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.6 | 11.0 | GO:0050544 | arachidonic acid binding(GO:0050544) |
1.6 | 7.9 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.6 | 60.6 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
1.6 | 1.6 | GO:0030351 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
1.5 | 1.5 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.5 | 7.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.5 | 7.6 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
1.5 | 12.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
1.5 | 38.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
1.5 | 7.6 | GO:0035671 | enone reductase activity(GO:0035671) |
1.5 | 10.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
1.5 | 18.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.5 | 6.0 | GO:0000403 | Y-form DNA binding(GO:0000403) |
1.5 | 7.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
1.5 | 4.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.5 | 3.0 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
1.5 | 47.3 | GO:0050840 | extracellular matrix binding(GO:0050840) |
1.5 | 10.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
1.5 | 7.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.5 | 17.5 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
1.5 | 23.4 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
1.5 | 21.8 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
1.5 | 8.7 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
1.4 | 4.3 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
1.4 | 5.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.4 | 78.5 | GO:0008013 | beta-catenin binding(GO:0008013) |
1.4 | 1.4 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
1.4 | 19.9 | GO:0019789 | SUMO transferase activity(GO:0019789) |
1.4 | 11.4 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
1.4 | 8.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.4 | 12.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
1.4 | 5.6 | GO:0046625 | sphingolipid binding(GO:0046625) |
1.4 | 2.8 | GO:0070878 | primary miRNA binding(GO:0070878) |
1.4 | 4.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
1.4 | 25.1 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
1.4 | 4.2 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
1.4 | 2.8 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
1.4 | 5.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.4 | 8.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.4 | 4.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
1.4 | 4.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
1.4 | 9.6 | GO:0043121 | neurotrophin binding(GO:0043121) |
1.4 | 6.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.4 | 4.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.4 | 1.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.4 | 14.9 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
1.4 | 10.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
1.4 | 1.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
1.3 | 4.0 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
1.3 | 46.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
1.3 | 4.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
1.3 | 2.7 | GO:2001070 | starch binding(GO:2001070) |
1.3 | 28.9 | GO:0017048 | Rho GTPase binding(GO:0017048) |
1.3 | 5.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
1.3 | 1.3 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
1.3 | 12.9 | GO:0043747 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
1.3 | 5.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
1.3 | 1.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
1.3 | 5.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
1.3 | 5.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
1.3 | 5.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.3 | 5.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.3 | 22.7 | GO:0051183 | vitamin transporter activity(GO:0051183) |
1.3 | 8.8 | GO:0017166 | vinculin binding(GO:0017166) |
1.2 | 5.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.2 | 21.2 | GO:0019239 | deaminase activity(GO:0019239) |
1.2 | 3.7 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
1.2 | 10.9 | GO:0009881 | photoreceptor activity(GO:0009881) |
1.2 | 22.7 | GO:0001968 | fibronectin binding(GO:0001968) |
1.2 | 19.1 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
1.2 | 8.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
1.2 | 3.5 | GO:0015232 | heme transporter activity(GO:0015232) |
1.2 | 1.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
1.2 | 2.4 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.2 | 2.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.2 | 5.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
1.2 | 3.5 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
1.2 | 2.3 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
1.2 | 47.7 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
1.2 | 10.4 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
1.1 | 4.6 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
1.1 | 3.4 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
1.1 | 9.1 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
1.1 | 18.1 | GO:0008483 | transaminase activity(GO:0008483) |
1.1 | 3.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
1.1 | 6.8 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
1.1 | 18.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.1 | 3.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.1 | 7.8 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.1 | 5.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
1.1 | 7.7 | GO:0039706 | co-receptor binding(GO:0039706) |
1.1 | 10.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
1.1 | 3.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.1 | 3.3 | GO:0031013 | troponin I binding(GO:0031013) |
1.1 | 1.1 | GO:0031996 | thioesterase binding(GO:0031996) |
1.1 | 3.3 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.1 | 9.8 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.1 | 1.1 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
1.1 | 4.3 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
1.1 | 6.5 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
1.1 | 2.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
1.1 | 1.1 | GO:0008142 | oxysterol binding(GO:0008142) |
1.1 | 7.5 | GO:0036310 | annealing helicase activity(GO:0036310) |
1.1 | 2.1 | GO:0048763 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
1.1 | 13.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
1.0 | 4.2 | GO:0043495 | protein anchor(GO:0043495) |
1.0 | 14.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
1.0 | 4.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.0 | 8.4 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
1.0 | 3.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.0 | 5.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
1.0 | 4.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.0 | 9.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
1.0 | 6.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
1.0 | 13.2 | GO:0035173 | histone kinase activity(GO:0035173) |
1.0 | 1.0 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
1.0 | 3.0 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
1.0 | 4.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
1.0 | 4.0 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
1.0 | 8.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.0 | 5.0 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
1.0 | 8.9 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
1.0 | 16.7 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
1.0 | 12.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
1.0 | 8.7 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
1.0 | 9.6 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
1.0 | 1.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.0 | 3.8 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
1.0 | 46.6 | GO:0008907 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.9 | 1.9 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.9 | 5.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.9 | 16.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.9 | 3.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.9 | 1.9 | GO:0070888 | E-box binding(GO:0070888) |
0.9 | 26.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.9 | 8.4 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.9 | 84.7 | GO:0008201 | heparin binding(GO:0008201) |
0.9 | 0.9 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.9 | 0.9 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.9 | 0.9 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.9 | 2.7 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.9 | 4.6 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.9 | 2.7 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.9 | 11.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.9 | 2.7 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.9 | 1.8 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.9 | 0.9 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.9 | 5.4 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.9 | 10.7 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.9 | 2.7 | GO:0035939 | microsatellite binding(GO:0035939) |
0.9 | 2.7 | GO:0043515 | kinetochore binding(GO:0043515) |
0.9 | 4.4 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.9 | 9.7 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.9 | 5.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.9 | 17.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.9 | 3.4 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.9 | 5.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.9 | 1.7 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.9 | 23.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.9 | 4.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.9 | 4.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.8 | 0.8 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.8 | 19.5 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.8 | 19.5 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.8 | 4.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.8 | 1.7 | GO:0097016 | L27 domain binding(GO:0097016) |
0.8 | 2.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.8 | 13.4 | GO:0001047 | core promoter binding(GO:0001047) |
0.8 | 2.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.8 | 9.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.8 | 1.7 | GO:0032052 | bile acid binding(GO:0032052) |
0.8 | 5.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.8 | 0.8 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.8 | 99.1 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.8 | 4.9 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.8 | 0.8 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.8 | 18.1 | GO:0019894 | kinesin binding(GO:0019894) |
0.8 | 1.6 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.8 | 13.1 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.8 | 1.6 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.8 | 4.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.8 | 0.8 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.8 | 74.9 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.8 | 7.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.8 | 3.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.8 | 12.8 | GO:0042805 | actinin binding(GO:0042805) |
0.8 | 4.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.8 | 0.8 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.8 | 3.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.8 | 8.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.8 | 26.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.8 | 11.8 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.8 | 22.6 | GO:0001012 | RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.8 | 0.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.8 | 3.1 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.8 | 11.4 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.8 | 3.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.8 | 48.2 | GO:0051015 | actin filament binding(GO:0051015) |
0.8 | 0.8 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.7 | 3.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.7 | 14.9 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.7 | 1.5 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.7 | 3.0 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.7 | 5.9 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.7 | 2.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.7 | 369.6 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.7 | 2.2 | GO:0004096 | catalase activity(GO:0004096) |
0.7 | 2.9 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.7 | 6.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.7 | 1.4 | GO:0010853 | cyclase regulator activity(GO:0010851) cyclase activator activity(GO:0010853) guanylate cyclase regulator activity(GO:0030249) guanylate cyclase activator activity(GO:0030250) |
0.7 | 5.8 | GO:0034778 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.7 | 5.0 | GO:0015266 | protein channel activity(GO:0015266) |
0.7 | 7.1 | GO:0008061 | chitin binding(GO:0008061) |
0.7 | 3.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.7 | 7.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.7 | 4.9 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.7 | 6.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.7 | 4.8 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.7 | 6.9 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.7 | 6.8 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.7 | 16.4 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.7 | 3.4 | GO:0034046 | poly(G) binding(GO:0034046) |
0.7 | 6.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.7 | 4.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.7 | 11.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.7 | 7.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.7 | 6.7 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.7 | 4.0 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.7 | 2.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.7 | 2.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.7 | 7.2 | GO:0005272 | sodium channel activity(GO:0005272) |
0.7 | 0.7 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.7 | 56.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.7 | 2.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.6 | 1.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.6 | 1.9 | GO:0030955 | potassium ion binding(GO:0030955) |
0.6 | 5.0 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.6 | 13.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.6 | 1.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.6 | 0.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.6 | 1.9 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.6 | 1.9 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.6 | 2.5 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.6 | 1.9 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.6 | 3.7 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.6 | 2.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.6 | 8.0 | GO:0005267 | potassium channel activity(GO:0005267) |
0.6 | 33.6 | GO:0000149 | SNARE binding(GO:0000149) |
0.6 | 1.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.6 | 1.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.6 | 1.8 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.6 | 52.3 | GO:0020037 | heme binding(GO:0020037) |
0.6 | 1.8 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.6 | 3.6 | GO:0034711 | inhibin binding(GO:0034711) |
0.6 | 5.4 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.6 | 11.2 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.6 | 22.4 | GO:0019003 | GDP binding(GO:0019003) |
0.6 | 2.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.6 | 0.6 | GO:0015927 | trehalase activity(GO:0015927) |
0.6 | 1.2 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.6 | 1.7 | GO:0000182 | rDNA binding(GO:0000182) |
0.6 | 4.0 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.6 | 1.1 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.6 | 1.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.6 | 1.7 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.6 | 41.5 | GO:0015293 | symporter activity(GO:0015293) |
0.6 | 0.6 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.6 | 5.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.6 | 1.1 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.5 | 2.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.5 | 3.8 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.5 | 0.5 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.5 | 2.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.5 | 7.9 | GO:0005109 | frizzled binding(GO:0005109) |
0.5 | 2.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.5 | 2.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.5 | 38.8 | GO:0003774 | motor activity(GO:0003774) |
0.5 | 1.6 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.5 | 1.6 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.5 | 20.8 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.5 | 5.1 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.5 | 0.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.5 | 10.8 | GO:0015485 | cholesterol binding(GO:0015485) |
0.5 | 1.0 | GO:0038100 | nodal binding(GO:0038100) |
0.5 | 0.5 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.5 | 10.2 | GO:0030145 | manganese ion binding(GO:0030145) |
0.5 | 385.5 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.5 | 2.0 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.5 | 3.0 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.5 | 1.5 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.5 | 1.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.5 | 3.5 | GO:0019864 | IgG binding(GO:0019864) |
0.5 | 1.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.5 | 4.0 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.5 | 34.5 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.5 | 1.5 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.5 | 0.5 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.5 | 79.6 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.5 | 1.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.5 | 0.5 | GO:0015491 | cation:cation antiporter activity(GO:0015491) |
0.5 | 5.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.5 | 2.8 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.5 | 0.5 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.5 | 36.6 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.5 | 5.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.5 | 1.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.5 | 3.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.5 | 2.8 | GO:0046790 | virion binding(GO:0046790) |
0.5 | 1.4 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.5 | 7.8 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.5 | 7.3 | GO:0019843 | rRNA binding(GO:0019843) |
0.5 | 5.0 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.5 | 6.4 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.5 | 2.3 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.5 | 67.3 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.5 | 0.5 | GO:0030519 | snoRNP binding(GO:0030519) |
0.4 | 0.9 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.4 | 4.4 | GO:0001848 | complement binding(GO:0001848) |
0.4 | 5.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.4 | 1.7 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.4 | 3.9 | GO:0019841 | retinol binding(GO:0019841) |
0.4 | 0.8 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.4 | 31.7 | GO:0005216 | ion channel activity(GO:0005216) |
0.4 | 2.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.4 | 0.4 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.4 | 16.6 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.4 | 2.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.4 | 2.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.4 | 1.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.4 | 2.0 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.4 | 1.2 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.4 | 6.5 | GO:0005518 | collagen binding(GO:0005518) |
0.4 | 4.8 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.4 | 0.4 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.4 | 1.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.4 | 1.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.4 | 0.4 | GO:0015081 | sodium ion transmembrane transporter activity(GO:0015081) |
0.4 | 1.2 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.4 | 6.2 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.4 | 1.2 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.4 | 0.4 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.4 | 1.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.4 | 1.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 1.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.4 | 18.0 | GO:0015923 | mannosidase activity(GO:0015923) |
0.4 | 1.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.4 | 4.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.4 | 3.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.4 | 0.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.4 | 14.5 | GO:0005543 | phospholipid binding(GO:0005543) |
0.4 | 12.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.4 | 1.4 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.4 | 6.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.4 | 0.4 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.4 | 3.5 | GO:0001618 | virus receptor activity(GO:0001618) |
0.4 | 6.7 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.3 | 0.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 0.7 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
0.3 | 1.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 1.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 0.3 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.3 | 3.1 | GO:0045182 | translation regulator activity(GO:0045182) |
0.3 | 0.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.3 | 1.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 1.0 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.3 | 0.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.3 | 9.5 | GO:0043022 | ribosome binding(GO:0043022) |
0.3 | 59.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.3 | 1.0 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.3 | 1.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.3 | 2.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 2.0 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.3 | 99.9 | GO:0005509 | calcium ion binding(GO:0005509) |
0.3 | 0.7 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.3 | 0.6 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.3 | 0.3 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.3 | 1.0 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 2.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.3 | 0.6 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.3 | 1.9 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.3 | 0.6 | GO:0071949 | FAD binding(GO:0071949) |
0.3 | 0.9 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.3 | 0.6 | GO:0043199 | sulfate binding(GO:0043199) |
0.3 | 3.4 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.3 | 0.9 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.3 | 0.3 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.3 | 1.2 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.3 | 16.9 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.3 | 0.3 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.3 | 0.9 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.3 | 0.6 | GO:0019002 | GMP binding(GO:0019002) |
0.3 | 2.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.3 | 0.9 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.3 | 1.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 1.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.3 | 0.9 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.3 | 21.2 | GO:0001664 | G-protein coupled receptor binding(GO:0001664) |
0.3 | 7.4 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.3 | 1.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.3 | 0.8 | GO:0004802 | transketolase activity(GO:0004802) |
0.3 | 3.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.3 | 2.5 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.3 | 0.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.3 | 0.8 | GO:0032404 | mismatch repair complex binding(GO:0032404) MutSalpha complex binding(GO:0032407) |
0.3 | 88.7 | GO:0005549 | odorant binding(GO:0005549) |
0.3 | 0.8 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.3 | 0.3 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.3 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.3 | 1.3 | GO:0031386 | protein tag(GO:0031386) |
0.3 | 1.3 | GO:0010181 | FMN binding(GO:0010181) |
0.3 | 3.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 0.8 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.3 | 0.8 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 3.3 | GO:0016782 | transferase activity, transferring sulfur-containing groups(GO:0016782) |
0.2 | 0.2 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.2 | 0.2 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.2 | 42.9 | GO:0019001 | guanyl nucleotide binding(GO:0019001) |
0.2 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 1.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 0.4 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.2 | 0.2 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 0.9 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.2 | 1.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 0.4 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.2 | 2.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 0.2 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.2 | 4.0 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.2 | 105.8 | GO:0008270 | zinc ion binding(GO:0008270) |
0.2 | 0.6 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.2 | 0.4 | GO:2001069 | glycogen binding(GO:2001069) |
0.2 | 0.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 12.9 | GO:0008017 | microtubule binding(GO:0008017) |
0.2 | 0.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 0.2 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 0.6 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.2 | 0.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 0.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 0.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.7 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.2 | 0.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 0.9 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.2 | 1.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 0.2 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.2 | 1.2 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 5.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 0.7 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 0.2 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.2 | 0.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 0.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.2 | 1.3 | GO:0005542 | folic acid binding(GO:0005542) |
0.2 | 0.2 | GO:0015079 | potassium ion transmembrane transporter activity(GO:0015079) |
0.1 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.1 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 2.7 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 1.5 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.1 | 0.3 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 6.7 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.3 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 0.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 1.0 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.7 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.7 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 0.1 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 0.1 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.1 | 1.5 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.1 | 0.6 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.2 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.1 | 73.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 0.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.2 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.1 | 0.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.3 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.3 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 2.0 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.1 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 0.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 0.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.3 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.8 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.1 | 0.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 1.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.4 | GO:0016160 | amylase activity(GO:0016160) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 4.1 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 1.3 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 0.1 | GO:0008169 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.1 | 0.2 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.1 | 0.1 | GO:0060229 | lipase activator activity(GO:0060229) |
0.0 | 0.0 | GO:0032564 | dATP binding(GO:0032564) |
0.0 | 0.4 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.0 | 6.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.0 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.3 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.2 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.1 | GO:0004529 | exodeoxyribonuclease activity(GO:0004529) exodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016895) |
0.0 | 0.1 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.0 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.0 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.0 | 0.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.8 | 319.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
7.4 | 162.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
6.3 | 81.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
5.9 | 170.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
5.1 | 92.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
5.1 | 96.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
4.9 | 34.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
4.3 | 89.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
4.1 | 98.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
4.0 | 56.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
4.0 | 80.0 | PID REELIN PATHWAY | Reelin signaling pathway |
4.0 | 115.3 | PID RAS PATHWAY | Regulation of Ras family activation |
3.9 | 50.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
3.7 | 51.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
3.1 | 65.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
3.1 | 73.3 | PID ARF6 PATHWAY | Arf6 signaling events |
2.8 | 66.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
2.8 | 83.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
2.7 | 16.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
2.7 | 43.6 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
2.6 | 7.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
2.6 | 92.1 | PID LKB1 PATHWAY | LKB1 signaling events |
2.3 | 16.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
2.2 | 2.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
2.2 | 2.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
2.2 | 41.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
2.0 | 2.0 | PID IGF1 PATHWAY | IGF1 pathway |
2.0 | 13.8 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
1.9 | 23.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.9 | 65.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
1.9 | 32.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.8 | 9.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
1.8 | 49.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
1.8 | 60.8 | PID BCR 5PATHWAY | BCR signaling pathway |
1.7 | 6.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.7 | 86.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
1.6 | 36.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
1.6 | 12.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
1.6 | 87.3 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
1.6 | 4.7 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
1.6 | 24.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
1.5 | 42.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
1.5 | 3.0 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.5 | 250.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
1.5 | 44.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
1.4 | 2.9 | ST GAQ PATHWAY | G alpha q Pathway |
1.4 | 19.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
1.4 | 15.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.3 | 21.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.3 | 2.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
1.3 | 7.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
1.3 | 7.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
1.3 | 11.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
1.3 | 53.5 | NABA COLLAGENS | Genes encoding collagen proteins |
1.3 | 11.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
1.2 | 7.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
1.2 | 15.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
1.2 | 10.8 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
1.2 | 4.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.1 | 15.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
1.1 | 16.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
1.0 | 10.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
1.0 | 13.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
1.0 | 9.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
1.0 | 4.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
1.0 | 28.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
1.0 | 12.8 | PID SHP2 PATHWAY | SHP2 signaling |
0.9 | 11.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.9 | 24.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.9 | 0.9 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.9 | 7.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.9 | 28.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.9 | 17.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.8 | 7.6 | PID FGF PATHWAY | FGF signaling pathway |
0.8 | 4.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.8 | 10.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.8 | 1.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.8 | 14.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.8 | 1.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.8 | 0.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.7 | 9.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.7 | 6.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.7 | 95.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.7 | 3.6 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.7 | 0.7 | ST STAT3 PATHWAY | STAT3 Pathway |
0.7 | 6.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.7 | 12.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.6 | 1.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.6 | 9.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.6 | 2.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.6 | 5.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.6 | 20.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.6 | 2.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.6 | 4.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.6 | 8.6 | PID ARF 3PATHWAY | Arf1 pathway |
0.5 | 4.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.5 | 0.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.5 | 5.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.5 | 0.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.5 | 5.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.5 | 2.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.5 | 12.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.5 | 4.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.5 | 1.9 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.5 | 3.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.5 | 5.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.4 | 0.9 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.4 | 2.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.4 | 9.0 | PID BARD1 PATHWAY | BARD1 signaling events |
0.4 | 2.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.4 | 3.7 | PID FOXO PATHWAY | FoxO family signaling |
0.4 | 2.0 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.4 | 2.7 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.4 | 2.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.4 | 0.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.4 | 4.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.4 | 67.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.4 | 1.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.3 | 77.5 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.3 | 2.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 20.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.3 | 0.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 3.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 1.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.3 | 7.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 1.5 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 2.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 1.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 1.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.9 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 1.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 2.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 0.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.0 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
24.5 | 367.8 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
7.7 | 77.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
6.6 | 92.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
5.5 | 16.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
5.5 | 236.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
5.5 | 43.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
5.2 | 57.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
4.9 | 44.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
4.9 | 127.8 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
4.5 | 45.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
4.4 | 44.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
4.4 | 52.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
4.4 | 4.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
4.3 | 43.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
4.3 | 43.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
4.2 | 137.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
4.0 | 76.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
3.8 | 7.6 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
3.7 | 15.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
3.5 | 14.0 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
3.5 | 76.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
3.5 | 38.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
3.4 | 65.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
3.2 | 124.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
3.0 | 54.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
2.9 | 31.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
2.7 | 18.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
2.6 | 21.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
2.6 | 51.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
2.6 | 58.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
2.5 | 30.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
2.5 | 17.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
2.3 | 25.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
2.3 | 44.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
2.2 | 17.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
2.2 | 54.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
2.1 | 17.1 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
2.1 | 68.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
2.1 | 20.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
2.1 | 14.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
2.0 | 18.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
2.0 | 14.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
2.0 | 8.0 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
2.0 | 25.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.9 | 25.3 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
1.9 | 16.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
1.8 | 27.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
1.8 | 18.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
1.8 | 43.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
1.8 | 19.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.8 | 57.3 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
1.8 | 8.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
1.8 | 22.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
1.8 | 49.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
1.7 | 22.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
1.7 | 17.2 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
1.7 | 17.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
1.7 | 1.7 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
1.7 | 26.6 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
1.7 | 26.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
1.6 | 23.1 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
1.6 | 4.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.6 | 39.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
1.5 | 17.0 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
1.5 | 27.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
1.5 | 20.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.5 | 122.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
1.4 | 15.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
1.4 | 15.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
1.4 | 16.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
1.4 | 19.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
1.4 | 18.9 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
1.3 | 14.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.3 | 17.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
1.3 | 11.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
1.3 | 21.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
1.3 | 63.9 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
1.3 | 7.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.3 | 64.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
1.2 | 3.7 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
1.2 | 17.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.2 | 8.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
1.2 | 12.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
1.2 | 10.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
1.2 | 1.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
1.2 | 19.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
1.2 | 13.0 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
1.2 | 12.8 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
1.2 | 5.8 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.1 | 18.9 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
1.1 | 7.8 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
1.1 | 9.9 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.1 | 17.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
1.1 | 4.4 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.1 | 9.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
1.1 | 16.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
1.1 | 68.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
1.0 | 17.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
1.0 | 17.3 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
1.0 | 25.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
1.0 | 8.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.0 | 15.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
1.0 | 20.0 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.9 | 1.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.9 | 3.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.9 | 21.1 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.9 | 11.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.9 | 1.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.9 | 29.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.9 | 0.9 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.9 | 29.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.9 | 2.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.9 | 30.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.8 | 20.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.8 | 3.3 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.8 | 10.5 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.8 | 6.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.8 | 7.0 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.8 | 4.6 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.8 | 4.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.8 | 117.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.8 | 13.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.7 | 5.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.7 | 39.1 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.7 | 2.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.7 | 2.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.7 | 2.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.7 | 7.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.7 | 7.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.7 | 11.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.7 | 8.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.7 | 4.0 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.7 | 9.4 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.7 | 11.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.6 | 33.1 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.6 | 9.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.6 | 2.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.6 | 11.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.6 | 8.9 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.6 | 4.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.6 | 6.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.6 | 3.7 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.6 | 3.7 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.6 | 4.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.6 | 7.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.6 | 2.9 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.5 | 5.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.5 | 8.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.5 | 0.5 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.5 | 2.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.5 | 4.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.5 | 5.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.5 | 30.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.5 | 6.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.5 | 3.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.4 | 1.7 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.4 | 2.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.4 | 3.0 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.4 | 3.8 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.4 | 0.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.4 | 11.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.4 | 1.2 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.4 | 5.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.4 | 7.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.4 | 64.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.4 | 1.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.4 | 1.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.3 | 4.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 15.2 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.3 | 6.0 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.3 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.3 | 0.3 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.3 | 13.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.3 | 7.7 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.3 | 1.9 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.3 | 12.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 2.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 1.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 0.9 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.2 | 3.7 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.2 | 1.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 2.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 2.8 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 4.6 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.2 | 4.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 1.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 2.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 2.3 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.2 | 1.0 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 0.3 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.2 | 0.3 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.2 | 0.3 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 1.9 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 0.7 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 0.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.7 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 5.1 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 2.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 1.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.3 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 1.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 0.2 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 1.0 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.1 | 0.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.1 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.1 | 2.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 2.4 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 1.4 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 0.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 1.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |